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ABSTRACT: 
IgG SUBCLASSES AND IMMUNOGLOBULIN ALLOTYPES IN CHILDREN 
WITH PULMONARY TUBERCULOSIS IN THE WESTERN CAPE. 
STUDY OBJECTIVES: 
An analysis of IgG subclasses and allotypes in children with pulmonary Tuberculosis (PTB) in 
the Western Cape. 
DESIGN: 
Consecutive children under 15 years of age with microbiological proven PTB over an 
8 month period- November 1993 to July 1994. 
SETTING: 
Teaching Hospitals in Cape Town. 
PATIENTS: 
Thirty-five cases were selected from 99 consecutive cases that were Mycobacterium 
tuberculosis positive, 15 of which were of Mixed and 20 were of Black Ancestry. 
CONTROL GROUP: 
Sera were selected from 224 Black Ancestry (59 children and 165 adults) and 211 Mixed 
Ancestry (67 children and 144 adults) that had no evidence for active tuberculosis 
or a history of previous TB diagnosis. 
MEASUREMENTS AND RESULTS: 
IgG subclasses, total IgG,and five allotypes: Glm(a), Glm(f), G2m(n), G3m(bl), G3m(gl) 
were determined by ELISA techniques. In the Mixed ancestry group the Glm(f) (p= 0.01), 
G2m(n) (p= 0.04) and G3m(gl) (p=0.001) allotypes were less frequently found in children 
with proven PTB. In the Black Ancestry subjects the G3m(g 1) allotype was significantly less 
common than in the control group (p < 0.001). 
CONCLUSIONS: 
Because allotypes are inherited in a Mendelian fashion, the observed association of childhood 
PTB and certain allotypes strengthens the hypothesis that a genetic susceptibility exists to 
acquiring TB. 
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CHAPTER 1 
IgG SUBCLASSES AND ALLOTYPES 
1.1 GOAL OF THIS STUDY 
To determine if a relationship exists between IgG allotype variability, the IgG subclass 
levels and infection withMycobacterium tuberculosis (M tuberculosis) in Black and 
Mixed Ancestry children of the Western Cape. If such a relationship can be established 
it may be possible to target specific groups of individuals for preventative, screening or 
interventio~ strategies. Such an association would also support the existence of a 
genetic predisposition to acquiring M. tuberculosis. High IgG subclass levels and 
certain Allotypes have been associated with protection against infection from 
encapsulated organisms. The levels of IgG Subclasses in M tuberculosis disease were 
therefor investigated. 
Specific objective 
The presence of five allotypes: Glm(a), Glm(f), G2m(n), G3m(gl) and G3m(bl) were 
determined and correlated with IgG subclasses levels in children with pulmonary 
tuberculosis. Allotypic frequency and IgG subclass levels were compared with a similar 
race and age matched control population. 
Hypothesis 
There is a significant association between the IgG allotypic expression and IgG subclass 
levels in Mixed Ancestry and Black children with pulmonary tuberculosis in the 
Western Cape. 
1.2 IgG SUBCLASSES 
1.2.1 Introduction 
The human Immunoglobulin system has five classes: IgG, MD, E and A. These classes 
differ in their antigenic determinants and physiological and biological activities. 
The basic molecular structure of the immunoglobulin molecule consists of 2 heavy and 
2 light chains each with variable and constant regions. The IgG structure consists of 
one pair of light chains (Lamda or Kappa) linked to one of 4 different heavy gamma 
chains. Each heavy and light chain has variable and constant regions of approximately 
110 amino acid residues. The constant regions of the different gamma chains exhibit 
significant sequence homology. 
Within IgG and IgA subclasses of immunoglobulin are recognized by the 
antigenic uniqueness of their heavy chains. These proteins are encoded separately 
within the heavy chain genome located on chromosome 14 at band 32 (Croce et al 
1979). The IgG subclasses also differ in their biological activities (see Table 1.1 ). 
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TABLE 1.1: IgG SUBCLASS BIOLOGICAL ACTIVITY 
IgGl IgG2 IgG3 IgG4 
Proportion of total IgG 60-65% 20-25% 5-10%
 3-4% 
Placental transfer ++ ± ++ 
++ 
Staphylococcus protein A + + 
+ 
binding 
F c Receptor binding: 
Monocytes +++ +++ 
++ 
Neutrophils + + 
Lymphocytes 
t Vi (days) 21-33 20-33 7-8 21-23 
Complement fixation +++ ++ ++++ 
± 
References: 
R Jefferis and D Kumararatne ( 1990) 
J Gibson (1987) 
1.2.2 Factors influencing subclass levels 
• Age 
The four subclasses differ in proportion and absolute levels accor
ding to age. IgG 1 and 
IgG3 attain adult levels at an earlier age than IgG2 and IgG4. No
rmal values should 
therefore always be interpreted according to age adjusted ranges (Lee et al 1986). 
• Antigenic stimulation 
Responses to protein antigens are produced predominantly by IgG
 1 and IgG3. 
Polysaccharide antigens evoke a heterogeneous response which i
s predominantly IgG2 
(Jefferis et al 1990). During prolonged antigenic stimulation, such as with pulm
onary 
tuberculosis, increased levels of lgG (total) and IgG4 occurs. Subtle differences
 and 
deficiencies of subclasses are difficult to interpret and may be ma
sked if only total IgG is 
measured. 
• Race and Sex 
Differences between White and Black American children have be
en documented 
(Shackelford et al 1985). There are also differences among the Mixed Ancestry
 and 
Black populations in the Western Cape (Goddard et al 1992). 
• Genetic factors 
Gm allotypes influence IgG subclass levels (Oxelius 1993a) and since IgG alloty
pes differ 
among population groups (see 1.3), where possible normal ranges, specific for e
ach 
grouping, should be used. 
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Deficiencies in lgG subclasses (mainly IgG2) have been associated with disease, 
particularly due to encapsulated organisms (Umetsu et al 1985). Pulmonary TB has not 
been associated with any subclass deficiency. 
1.3 IgG ALLOTYPES 
1.3.1 Introduction 
Allotypes are specific genetic variants of light and heavy chains of the Immunoglobulins. 
They are due to alleles on the lg constant region genes that differ mostly in single amino 
acid sequence changes. Allotypes are inherited in a Mendelian fashion. The functional 
value of these variants is not known but a number of associations that relate to 
immunoglobulin production and disease have been found. There are multiple allotype 
alleles of IgG 1 and IgG3 subclasses, one recognised allele for IgG2 subclass and two for 
IgA. On the kappa light chain 3 alleles are recognized (Table 1.2). 
TABLE 1.2: HUMAN IMMUNOGLOBULIN ALLOTYPES 
Heavy Chains 
IgGl 
IgG2 
IgG3 
IgA2 
IgE 
Light chains 
Kappa 
Domains 
CH3 
CH3 
CHI 
CHI 
CH2 
CH3 
CH2 
CH3 
CH2 
CH3 
CH2 
CH3 
CH2 
CH3 
CH3 
CH3 
CH3 
CH3 
CH2 
CH3 
Allotypes 
Alphabetical Numerical 
Glm(a) Glm(l) 
Glm(x) Glm(2) 
Glm(f) Glm(3) 
Glm(z) Glm(17) 
G2m(n) G2m(23) 
G3m(b0) G3m(11) 
G3m(bl) G3m(5) 
G3m(b3) G3m(13) 
G3m(b4) G3m(14) 
G3m(b5) G3m(l0) 
G3m(gl) G3m(21) 
G3m(g5) G3m(28) 
G3m(u) G3m(26) 
G3m(v) G3m(27) 
G3m(s) G3m(15) 
G3m(t) G3m(16) 
G3m(c3) G3m(6) 
G3m(c5) G3m(24) 
Am(l) 
Am(2) 
Em(l) 
Km(l) 
Km(2) 
Km(3) 
Reference:WHO Notation for genetic factors of human immunoglobulins. Bull Wld lllth Org 1965; 33:721. 
Lcfranc and Lefranc: 1990 
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The nonmenculature has evolved in an alphabetical or a numerical system. In this thesis the 
alphabetical system is used. 
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Combinations of allotypes, called haplotypes, are characteristic for population groups (Lefranc 
and Lefranc 1990, Steinberg 1973, Steinberg 1969 Johnson et al 1977). 
Haplotypes found commonly among: 
• Caucasians: 
Gm b, f, n, U, V 
Gm b, fu, V 
Gm g, a, Z, U, V 
Gm g, a, x,-·z, u, v 
• Negroid population haplotypes 
Gm b, a, Z, V 
Gm b, C, a, z, U, V 
• Khoisan haplotypes 
Gma,z,g 
Gm a, b, z 
• Mongolian haplotypes 
Gm b, v, a, z 
Gm b, u, v, a, f, n 
1.3.2 Specific allotypes 
Gm allotypes 
Glm(a) consist of2 point mutations on the CH3 homologous region of IgGl heavy 
chain. Glm(f) and Glm(z) are genetically linked and are due to different point 
mutations at the same position in the CH 1 homologous, region and thus would be 
expressed reciprocally.G2m(n) is the only allotype recognised for IgG2 and is found on 
the CH2 domain. The G3m(b1) allotype is carried on the CH2 domain as is G3m(g1). 
All the allotypes have iso-allotypes found on the other IgG subclasses (Lefranc and 
Lefranc 1990). This has relevance when quantitation is done using monoclonal specific 
antibodies in the ELISA system. The presence (and detection) ofiso-allotypes can give 
spurious results if the relevant IgG subclass is not selected by capture ELISA 
techniques. G3m(b1) allotype is carried in close proximity to a number of other 
allotypes. Thus G3m(b1), (b0 ), (b5) and (b3) markers are collectively referred to as 
G3m(b). 
Km allotypes 
The three alleles are all on the constant region of the kappa light chain: Km( 1 ), 
Km(l,2) and Km(3). The differences amount to single amino acid substitutions. 
Km(l) is rare in Caucasians (8%) and present in about 50% of Negroids (Lefranc and 
Lefranc 1990). 
Factors influencing allotypic expression 
Conformational changes in vitro which could be responsible for epitope masking may 
influence allotype detection. Heterozygosity for the specific allotypes is known.( 
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Oxelius et al 1993b) Factors such as age, sex and infection have not been found to 
alter expression of allotypes ( Goddard 1994). 
1.3.3 Allotypes IgG Subclasses and disease associations 
1. IgG subclass levels 
1..f 
Certain allotypes in some population groups have been associated with
 decreased 
levels of a particular subclass (IgG2 and G2m(negative) (Oxelius 1993a) or 
increased levels, IgG3 and G3m(b) (Morrel et al 1972, Jefferis et al 1990). The 
influence of Glm(a) and Glm(f) on subclass levels has not been well defined. 
Goddard (1994) found that Glm(f) marker had a negative effect on IgG (total) and 
IgGl levels in the Mixed Ancestry children studied in Cape Town. Th
is is the 
opposite of the findings in the Finish population (Sarvas et al 1991). The G2m(n) 
marker has also been associated with altered IgG subclass levels ( Grano ff et al 1992, 
Jefferis et al 1990). 
n. Antibody production to vaccines 
Sarvas et al (1989) found higher IgG2 subclass antibodies against pneumococcal 
polysaccharides in Finish homozygotic individuals whom expressed G2
m(n). In 
black (Negroid) children the IgG antibody response to H. influenzae polysaccharide 
vaccine was found to higher in those who expressed Km(l) and G2m(n) (Granoff 
1986). 
iii. Immune mediated diseases 
A number of autoimmune diseases including multiple sclerosis, rheum
atoid arthritis 
and systemic lupus erythematosis have been associated with various al
lotypes 
(Dogoryan JM, Guitard E, Seregas MT 1992). Recently an association with 
Kawasaki disease has also been reported (Shulman 1993). 
iv. Bacterial infection 
Granoff and others (1984) reported a decreased susceptibility among black USA 
children who expressed Km(l) allotype to infection with H. influenzae meningitis. 
In Mixed Ancestry children with invasive H. injluenzae infection G2m(n) and Km(3) 
were less frequent, whereas in Black children only Km(3) was decreased (Goddard 
1994). 
It therefor appears that allotypes do influence a number of disease rela
ted factors but 
not in a consistent manner. 
1.3.4 Literature review of allotypes and M tuberculosis 
Publications on the association between allotypes and M tuberculosis are
 limited to 
three articles; one in an adult Indonesian population, the other in a Ru
ssian group of 
adult patients and in a Tuvinian childhood population. 
Gibson and others (1987) reported on a study group of 121 smear-positive pulmonary
 
tuberculosis patients and 33 healthy controls from the same town in E
ast Java. Their 
important findings were: The Km(l) allotype occurred significantly less in tuberculosi
s 
patients than among controls and the phenotypes which lacked Glm(z), G3m(gl) and
 
Km(l) were more common amongst the TB group. Anti-mycobacterial antibody leve
ls 
were also influenced by allotypic expression in that IgG2 specific antib
ody was 
decreased in those without G 1 m(z) or G3m(g 1 ). IgG4 specific antibody levels were 
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elevated if the Km(l) allotype was present. G2m(n) was not tested. In this study a 
large panel covering Glm, G3m and kappa allotypes were tested. The populations 
genetic diversity is well illustrated by the excess of 10 phenotypes found. A very small
 
control group (33) could have influenced their results. Of all those having tuberculosis 
in the study group only a third had a phenotype that differed from the control group. 
The strength of the allotypic association was therefore only modest. 
Chukanova and others (1994) studied 214 adults with pulmonary tuberculosis and 203 
controls. They looked at HLA typing, erythrocyte enzymes and IgG allotypes. The 
most significant finding was that HLA DR7, Hp 1-7 and the absence ofGlm(a) and 
Glm(x) in the presence ofGlm(f) was associated with a f;ivourable outcome. HLA 
DR2, Hp 2-2 and the absence of Glm(x) but the presence of Glm(a) and (f) led to 
chronicity, judged by chest X-rays at the end of a course of standard therapy. The 
authors used a limited phenotypic panel and could not demonstrate a difference 
between controls and patients but only a difference amongst patient outcome at 
termination of therapy. 
Matrakshin and others (1993) found among a number of polymorphic systems, 
including HLA-typing and red blood cell enzymes, that there was a positive association
 
in the 73 children with Glm(x) and tuberculosis in comparison with the 273 child 
controls. This was so for the group that expressed Glm(x,a,f). 
Conclusion: 
Some evidence, albeit inconclusive, exists that IgG allotypic expression influences 
and/or modifies susceptibility to M tuberculosis infection. 
1.3.5 Selection of phenotypic panel in this study 
To determine the influence of allotypic expression in M tuberculosis the following 
factors were considered in selecting allotypes for the study: 
a. Allotypes identified from previous work with M tuberculosis: Km( 1) and 
G3m(gl) (Gibson 1987) and Glm(a); Glm(f) (Chukanova 1994). 
b. Allotypes associated with IgG subclass expression: G3m(g
1) and G3m(b1) 
(Jefferis and Kumararatne 1990), G2m(n) (Oxelius 1993a). 
c. Allotypes that are prevalent in the Western Cape population under study: 
Blacks Mixed Ancestry 
Kml 
Glm(a) 
Glm(f) 
G2m(n) 
G3m(bl) 
60% 
99% 
<3% 
3% 
64% 
Reference: Jenkins 1970, Goddard 1994. 
1.4 MYCOBACTERIUM TUBERCULOSIS 
1.4.1 Introduction 
'7 
58% 
30% 
44% 
53% 
The World Health Organisation (WHO) estimates that one third of the world's 
population is infected with M. tuberculosis. This figure might be as high as 40% in 
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sub-Saharan Africa. In South Africa the overall incidence rat
e for 1992 was 366: 100 
000 (Eggers et al 1994). In the Western Cape there is an alarming incidenc
e rate of 
718: 100 000 among the Mixed Ancestry population group. I
t is calculated that this 
group is experiencing a bimodic epidemic curve: one part of
 the community having a 
decreasing and the other (younger) section an increasing incidence (Kustne
r 1995). 
The high incidence rate among the Mixed Ancestry populatio
n group in the Western 
Cape has not been adequately explained. Socio-economic fa
ctors that promote M 
tuberculosis infection are an obvious factor. Poor living conditi
ons and overcrowding, 
the extent of case finding and of contact screening are impor
tant in determining the 
incidence of infection but it is possible that other factors sµch
 as genetic influences may 
also play a role. 
1.4.2 Bacteriology 
M tuberculosis was first described by Robert Koch in 1882 and
 has since been studied 
intensively, but, there is still more to unravel. 
M. tuberculosis is a facultative intracellular pathogen and resem
bles other pathogens 
such as Leishmania, Toxoplasma gondii and Legionella pneum
ophilia (Kaufman 1993). 
These organisms enter humans' cellular milieu via the macro
phage and escape 
intracellular killing for some time, giving rise to their progre
ssive local and systemic 
effects. Furthermore they have the ability to remain dormant
 in the human body and to 
multiply many years later. Within the human body, under cer
tain conditions, organisms 
multiply extracellularly an example being pulmonary cavities 
where M tuberculosis 
bacilli lie free within the caseous material. 
M tuberculosis is also characterised by its slow dividing time (doubling tim
e± 12-20 
hours) (Wheeler 1988) and its ability to survive outside the human host for
 long periods 
(Nyka 1974). The nutrients needed for in vitro culture is nothing more tha
n the usual 
organic carbons, nitrogen and trace elements (Wheeler 1988). 
The cell wall consists of a plasma membrane, the cell wall pro
per and an outer attached 
capsule (Draper 1982). All three structures consist mainly of lipids giving 
it it's 
waxiness and characteristic acid fast staining property. The s
keleton or supporting 
framework is made up from peptidoglycans (polysaccharides), arabinogala
ctan and 
mycolic acids. Also attached to the skeleton are glycolipids a
nd proteins. 
Lipoarabinomannan (LAM) is one such glycolipid that produces a strong 
immunological response although not unique to M tuberculosis
 (McNeil and Brennan 
1991). Other glycolipids that are important immunologically are the sulpha
tides. 
The characteristics of the cell wall and the slow adaptive met
abolism is most likely 
responsible for the innate ability of the organism to resist the
 human host defence 
mechanisms (Ehlers 1993). 
1.4.3 Host immune responses to M. tuberculosis 
Recent reviews on this topic by Dunlop and Briles (1993 ); Buschman and 
Skamene 
( 1988); and Edwards and Kirkpatrick (1986) have been published. 
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Droplets containing live M tuberculosis bacilli are inhaled and ingested by alveolar 
macrophages. Multiplication progresses until a threshold is reached (4-8 weeks later), 
when bacilli are transmitted via lymphatics to regional lymphnodes or via the 
bloodstream to distant sites. 
M tuberculosis enters macrophages by a process of phagocytosis. The probable 
binding sites - called ligands - of M tuberculosis are complement receptors three and 
four (also known as MACI, part of the 82 family) (Schlesinger et al 1990). This 
binding enables the bacillus to avoid the respiratory burst and also interferes with the
 
phagolysome-lysosome fusion process. The other factors that aid evasion of 
intracellular killing are the waxy coat, the sulfatides (high Jnolecular weight glycolipid 
sulfates), lipoarabinomannan and increased adenosine monophosphate production by 
the bacillus.-(Dunlop and Briles 1993). 
The Cellular immune response is initiated by clonal expansion of primed T-helper cel
ls 
that activate peripheral macrophages by gamma interferon production. Delayed 
hypersensitivity (DTH) develops which is characterised by skin reactions to 
intradermally injected PPD (purified protein derivative). The DTH response is probaly 
T-cell dependant and leads to macrophage killing and tissue damage by liquefaction. 
The T-helper subsets Thl and Th2 and cytotoxic T-cells (CDS+) each produce a typical 
cytokine pattern: Thl cells mainly interferon gamma (IFNy),interleukin-2 (IL-2) and 
tumour necrosis factor beta (TNFl3) and Th2 cells IL-4 and IL-10. Once activated 
through INFy, macrophages can then kill off the bacilli. Natural killer cells lyse other
 
cells to liberate M tuberculosis bacilli which can then be phagocytosed effectively by 
activated macrophages and this leads to an abated initial infection. If the DTH respon
se 
predominates, liquefaction and caseation causes extensive tissue damage. (Kaufman 
1993, Dunlop 1993). 
The humoral immune response to M. tuberculosis infection has been mostly regarded 
as non-protective and in many instances detrimental. An association between 
disseminated disease and high antibody titres has also been described (Lenzine et al 
1977). It is tempting to speculate that the high IL-4 levels, causing high antibody levels 
in patients with M tuberculosis, could be determental to the host defence due to down 
regulating the Thl response (Surcel et al 1994) 
Antibodies may however be protective. The following evidence from the literature 
supports this: 
a. A study of childhood tuberculosis found the highest specific M tuberculosis 
antibody titres in circulating immune complexes from children with healed 
pulmonary tuberculosis and calcified chest lesions, but lower levels in children with 
miliary tuberculosis (Ashtekar et al 1992). 
b. Specific antibodies to certain cell membrane antigens of M tuberculosis i.e. 
lipoarabinomannon (Costello et al 1992) and the 38-kDa protein (Harboe 1992) 
might have protective value since they are associated with localised disease and not 
with dissemination. 
c. In animal models it is reported that specific anti-mycobacterial antibodies impair
ed 
delayed hypersensitivity reaction in rats skin tested with PPD (Drexhage et al 
1980). 
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d. Other evidence comes from a study on macrophages of mice infected by
 
mycobacterium bovis (Forget et al 1976). When the sera of mice that have 
overcome the disease were added to in vitro cultures this resulted in enhance
d 
killing of M. tuberculosis by macrophages. 
e. Specific antibodies when present in autologous serum, increases the deg
ree of 
lysosomal fusion with the phagosomal membrane in human macrophage cult
ures 
infected with M.bovis (Armstrong et al 1975). 
One can therefore conclude that antibodies against mycobacterial species ma
y play a 
immune modulating role. 
As a diagnostic tool antibody measurement has not yielded promising results
, mainly 
because of the inability to find discriminating antibody levels between dorma
nt and 
active M tuberculosis infection. 
1.4.4 Genetic susceptibility 
Genetic susceptibility to mycobacterium species is a much more vexing quest
ion. To 
support this theory the following is quoted: 
Epidemiological evidence: 
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a. Twin studies: concordance for tuberculosis was higher among monozyg
otic than 
dizygotic twins (Canstock 1978). 
b. Studies on USA racial groups in similar environments indicated a higher
 
susceptibility to M tuberculosis.(Stead et al 1990). 
LaboTatory investigations: 
a. In vitro studies on macrophage killing ability that differs between Negro
id and 
Caucasian (Crowle 1990). 
b. Murine models in which the 'BCG' gene mapped on chromosome 1 rend
ered the 
animal resistant to M.bovis (Skamene 1989). Recently linkage studies have shown 
that in the human genome homology exist on Chr 2q with the Beg gene in th
e 
mouse. (Skamene E 1994). 
c. Decreased production of tumour necrosis factor (a cytokine responsible for 
macrophage activation) in four genetically related children from Malta with atypical 
mycobacterial disease (Newport and Levin 1994). 
Genetic determined markers: 
A worse outcome in pulmonary tuberculosis in patients with I-ILA DR2 (Chukanova et 
al 1994) and MHC class III C4A component (Santos et al 1994) has been described. 
Associations between tuberculosis and immunoglobulin allotypes have also b
een 
described (Gibson et al 1987; Chukanova et al 1994; Matrakshin et al 1993). 
There are fierce opponents of the genetic susceptibility hypothesis who claim
 that 
environmental factors such as overcrowding and other health issues includin
g nutrition 
and poor case and contact tracing plays the most important role in rendering
 the host 
susceptible (Kushigemachi et al 1984). 
1.5 Rationale for the study 
From the literature review it is clear that M tuberculosis is still highly prevalen
t and 
will possibly become the most important infectious disease in sub-Saharan A
frica. 
Although cellular immune mechanisms play a dominant role, humoral respon
ses could 
at the very least modify the disease process. There is some evidence that gen
etic 
susceptibility to M tuberculosis exists. Allotypic markers oflgG are geneticall
y 
determined and thus provides a way of studying the genetic determined respo
nses to 
mycobacterial infection in humans. 
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CHAPTER2 
STUDY DESIGN 
2.1 STUDY DESIGN AND POPULATION DEFINITIONS 
The study was undertaken in conjunction with a parallel study 'The immunological 
aspects of pulmonary tuberculosis in association with Vitamin A supplementation in 
children of the Western Cape' (principal author W Hanekom) between August 1993 
and June 1994. Approval by the Ethics and Research Committee of the University of 
Cape Town was obtained prior to embarking on this study. 
2.1.1 Population definitions 
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Black population: In accordance with accepted usage 'Black' is employed for 
describing persons of indigenous African lineage. The population in the Western Cape 
are largely Xhosa speaking. 
Mixed Ancestry population: The term 'mixed ancestry' is used to describe this group 
rather than Coloured or Cape Coloured. The population has a mixed lineage in origin. 
(see section 2.3.2.) 
2.2 PATIENT COHORT 
2.2.1 Criteria for selection 
The patient cohort comprised of 99 consecutive children with suspected M. 
tuberculosis disease who presented themselves or were referred for in-patient treatment 
at three paediatric training hospitals in Cape Town. Their ages ranged from 3 months 
to 14 years and 3 months. The World Health Organisation criteria (WHO) were used to 
make the diagnosis of active M. tuberculosis disease (Table 2.1 ). Only the 3 5 patients 
with microbiological confirmation for M tuberculosis were selected for further analysis 
of the IgG subclasses and allotypes. 
Exclusion criteria were the following: 
1. Recent (within 3 months prior) use of high dose Vitamin A therapy since the 
immunological effects of Vitamin A supplementation was studied as well. 
11. The use of steroids. Most of the children with Tuberculous meningitis (TBM) 
received oral prednisone for prolonged periods (28 days) and were excluded due 
to the effect of steroids on immunological measurements. Only 1 TBM child was 
included in the study. 
111. Children with skeletal manifestation of tuberculosis as a presenting feature were 
generally not available for selection. 
iv. Refusal by parent or caretaker for blood sampling. 
Thirty five children (female 15; male 20) were included of whom 20 were Black and 15 
of Mixed Ancestry. 
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TABLE 2.1: WHO CRITERIA for the diagnosis of Pulmonary Tuberculosis in 
children under five years of age. 
Suspected case: 
• An ill child with a positive contact 
• Any child who doesn't return to normal after measles or whooping cough. 
• Any child with loss of weight, cough and wheeze who doesn't respond to 
antibiotic therapy. 
• Any child with abdominal swelling or a hard painless mass and free fluid. 
• Any child with painless firm swelling in a group of superficial lymph nodes. 
• Any bone or joint lesion of slow onset. 
• Any child with signs suggesting of meningitis. 
Probable Tuberculosis: 
• A suspect case with: 
> 10 mm induration on tuberculin reaction; 
Suggestive radiological appearances on chest, bone or joint films; 
Suggestive histological findings in biopsy material; 
Favourable response to specific antituberculosis therapy. 
Confirmed Tuberculosis. 
• A probable case with: 
Microscopic detection of tubercle bacilli from secretions or tissues; 
The identification of the tubercle bacilli asMycobacterium tuberculosis by 
culture characteristics. 
2.2.2 Data collected 
Demographic data 
The age, sex, race and permanent address were collected. Factors relating to social 
status and housing conditions, as well as the caretaker and disease contacts were 
recorded. Immunisation status, birth history and birth place were also recorded. 
Clinical symptoms and signs 
Symptoms pertaining to anatomical localisation, hypersensitivity phenomena and 
malnutrition were illicited. Each child was fully examined and the findings recorded. 
Skin testing 
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Mantoux responses were recorded 72 hours after administration of PPD intradermally. 
Not all the patients could be personally seen after injecting the PPD and the 72 hour 
recordings were therefore done by multiple health professionals. 
Chest X-rays 
Chest X-rays were obtained at diagnosis, at 6 weeks and at 12 weeks and were 
reported on by one radiologist in the radiology department at the Red Cross Children's 
Hospital. 
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The X-ray appearances were recorded and classified into pathological groupings: 
Primary pulmonary TB 
Progressive pulmonary TB 
Post primary/secondary TB 
2.2.3 Disease severity score 
Lymphadenopathy only and/or 
Single parenchymal lesion with 
lymphadenopathy 
Lymphobronchial disease with or without 
airway impingement and/or 
Haematogenous dissemination and/ or 
Pericardia} disease and/or 
Pleural disease 
Cavitation ot fibrosis with or without 
calcifications. 
To compare the extent of pulmonary TB among subgroups several authors have used 
different criteria. Some include symptoms that relate to the disease, specific signs of 
the disease; special investigations such as X-rays or bacteriological results and respons
e 
to therapy (Tidjani et al 1986). Allotypes could be associated with disease modulation 
and therefore a severity score was developed. This score system uitilises ag~, 
nutritional status, X-ray appearances, haemoglobin and albumin values. (Table 2.2) 
TABLE 2.2: SEVERITY SCORE 
0 1 2 
Nutritional status: ~ 95% of mean 87-94% of mean < 87% of mean 
( weight for height mean) 
Albumin 
Haemoglobin 
Chest X-ray appearances 
Age: 
~ 32 g/dl 
~ 10.5 g/dl 
Primary 
> 5 years 
25-31.9 g/dl 
8.5-10.4 g/dl 
Progressive 
2-5 years 
< 25 g/dl 
< 8.5 g/dl 
Secondary 
< 2 years 
The following statements are made to motivate the selection of age, nutritional status, 
X-ray appearances and two laboratory parameters: 
M. tuberculosis induces acute malnutrition as is clear from children with extensive 
disease (Hussey et al 1991). Weight for height was used to eliminate the effect of 
chronic malnutrition that is associated with patients from poor socio-economic 
backgrounds as was demonstrated in a group similar to this study population (Hugo-
Hamman 1987). 
The common finding of disseminated M tuberculosis occurring in younger children 
(Seth et al 1993; Sinder et al 1988; Jacobs et al 1993) warrants the inclusion of age in 
the severity score. 
Chest X-ray appearances correlate with the known pathophysiology of the disease 
progressing from the Gohn complex to lymphogenic or bronchogenic spread and later
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tissue necrosis and cavitations (Dunlop et al 1993). Miliary (pulmonary) tuberculosis 
was grouped under progressive primary disease due to this pathophysiological concept. 
Since age was used as a denominator and most miliary M tuberculosis occurs in the 
under 2 age group (Hussey et al 1991) this specific chest X-ray appearance was not 
weighted separately. 
The haemoglobin and serum albumin values were included due to the known effect of 
M tuberculosis on bone marrow suppression and its effect on general nutrition 
(DesPrez et al 1990). 
2.3 CONTROL GROUP 
2.3.1 Selection · 
The control group consisted of four separately collected cohorts: 
1. Children of Mixed Ancestry (67): Aged 6 m - 13 years. Sampling was done in 
conjunction with the National Nutrition and Vitamin A Survey (1994). All the 
children's growth parameters were checked and examined clinically to exclude 
lung pathology. Blood was obtained with written consent. 
Mixed Ancestry adults (144): Ages were not recorded. Volunteer blood donors 
were asked to donate an extra sample. Each donor was weighed, haemoglobin 
checked and a health questionnaire completed. Only samples from individuals 
that were not ill by these criteria were selected. 
Total Mixed Ancestry group: (211) 
11. Black children (59): Aged 6 to 18 months. Samples were obtained as part of 
measles vaccination intervention study (Hussey G personal communication 1993). 
All patients were examined and growth parameters recorded. Only healthy 
children were selected. 
Black adults (25): Volunteer blood donors were screened in the same way as the 
blood donors of the Mixed Ancestry group (see (i) above). 
Black adults ( 149): A cohort screened for sexually transmitted diseases. All 
patients were examined and weighed and patients without chest symptoms and 
who were HIV negative were selected 
Total Black race group: (233). 
2.3.2 Genetic composition 
Mixed Ancestry population 
The Western Cape Mixed Ancestry population has its origins routed in an admixture 
of a number of different race groups. 
The first inhabitants of the Western Cape are by all accounts ( verbal, written and 
archaeological) a group called Khoi or also known as Hottentots (±AD 1500). The 
Khoi and another closely related group San (Bushmen) shared geographical areas 
with the Khoi being pastorlists and the San the hunters. With increasing pressure on 
both groups by other occupants (European and African) the two groups became 
intermingled and are now referred to as the Khoisan. 
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From historical facts the groups contributing to the Mixed Ancestry population group 
in the Cape were: Hottentots (Khoi), Caucasian (Western Europe), Bushmen (San) 
and freed slaves (Negroid and Indonesian from Madagascar, Java and Sumatra) 
(Marais 1957). But also from data based on genetic markers that included 
immunoglobulins, blood groups, red blood cell enzymes and serum proteins the 
contributing groups are the same namely Khoi, San, European, Negroid and 
Indonesian (Nurse et al 1985). 
The relative contribution of each of the race groups to Cape Mixed Ancestry 
population group is virtually impossible to determine. No important founder-gene 
abnormalities identify this group and due to the many di:lferent factors involved in 
gene drift _each race group's contribution cannot be accurately established. 
This group can be expected to share some common genetic inherited markers with its 
neighbours such as the Nguni. The Nguni who some time later became the Black 
Xhosa speaking group has been included in this study. 
The present day Mixed Ancestry population group was formed in the late l 700's and 
has developed it's own socio-cultural identity in many aspects, especially as a result of
 
Apartheid laws. Although further racial admixture would have continued, but on a 
much smaller scale, it can at present be considered as a fairly homogenous group. 
Black population 
The Black Xhosa speaking population group in the Western Cape is closely related to 
the other Nguni Bantu groups: Pedi and Zulu. The Nguni pastoralists are grouped 
together and separated from the Sotho-Tswana Bantu by linguistic and social 
characteristics. The Sotho of the early Iron Age inhabited mainly the interior plateau 
regions and came into close contact with the San - assimilating some of the language 
characteristics, whereas the Nguni inhabited the coastal regions migrating gradually 
southwards from present day Swaziland (Oliver and Fagan 1975). 
Clear distinction between the present day Nguni groups evolved during the late 16th 
and early 17th centuries after the Mfecane - an event oflarge scale upheaval involving 
most of the Negroid groupings of Southern Africa. Pressures relating to European 
occupation of the Southern Cape regions, population growth and the need for 
increasing land usage common to the pastoral life style, and dominating groups such 
as the Zulu under Chief Chaka, are all factors that contributed to the Mfecane. 
There is evidence that the Xhosa group has assimilated some of the Khoi members 
when judged by allotypic expression (Steinberg et al 1975), linguistic characteristics 
(Maingard 1934) and historical evidence. This is also supported by archaeological 
findings which dates early Bantu and Koisan inhabitations during the early Iron Age to
 
the same geographical areas covering most of the eastern Southern Africa coastline 
(Oliver et al 1975). 
The important episodes of population upheaval and possible genetic related changes 
are listed below (Nurse et al 1985): 
Cfl ll'"fFR :!: .\Tl Dr DFSJG.\ 
Date 
1713 
Early 
1800's 
Source 
Small pox 
epidemic 
Mfecane 
People group 
Khoi 
Nguni 
Effect 
Movement away from 
Southern Cape towards 
Namibia and Northern Cape 
Northward migration 
towards Malawi 
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Changes brought on by present day economic factors (such as urbanisation) and apartheid laws 
(migrant labourers) have probably not changed the genetic composition significantly although 
this has not been formally studied. 
This suggests that ·since the mid 19th hundred century no major factors involving genetic 
admixture has occurred in the two population groups under study 
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CHAPTER3 
METHODS 
3.1 CLINICAL DATA CAPTURE FORM 
All the data collected was recorded on a specially devised questionnaire and later 
transferred to an analytic programme (Epiinfo, Version 6). See Appendix 6. 
3.2 ELISA TECHNIQUE 
25 
All allotypes were tested by ELISA techniques. Of the five ELISA tests used, three 
were newly established tests for this laboratory The IgG subclasses were measured b
y 
techniques established in the Immunology Laboratory at the Red Cross Children's 
Hospital (Goddard et al 1992). 
Written consent was obtained from the parent(s) or accompanying caretaker before 
blood was taken from the child. The sera were separated and aliquoted on the day o
f 
collection and stored at -70°C until analyzed. 
3.2.1 Introduction to the ELISA technique 
The enzyme linked immunosorbent assay, was developed from the older radioimmun
o 
assay where a solid support was used to bind antibody. Radio labelled antigen was t
hen 
captured and analyzed. In 1972 Engwall and Perlmann described a refined method by
 
which antibodies were linked to an enzyme (alkaline phosphatase) for detecting antigen 
on a solid phase. With the addition of a suitable substrate and a chromogen, 
measurement by spectrometry could be undertaken. 
Allotypes were measured previously by haemagglutination methods and this has 
remained the gold standard (De Lange et al 1989). As newer and more specific 
antibodies and reliable reference sera became available the ELISA technique has been
 
used more extensively. The ELISA technique has some major advantages over 
haemagglutination (Table 3 .1 ). 
TABLE 3.1: HAEMAGGLUTINATION VERSUS ELISA TECHNIQUE 
Methodology 
Ease 
Time 
Reproducibility 
Costs 
Moab* availability 
Quantitation 
Samples done per run 
Haemagglutination 
+ 
+++ 
++ 
++ 
+ 
Not possible 
10-20 
* Moab = Monoclonal antibody 
ELISA 
++ 
++ 
++ 
+ 
+++ 
Possible 
>40 
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The greatest limitation of the ELISA technique is the lack of specific and suitable 
antibodies for a few remaining allotypes (Nelson et al 1990). 
3.2.2 Description of methods used: (Detailed description included in Appendices) 
Indirect ELISA: (Allotyping - Glm(a), Gm(f), G2m(n), G3m(g
1)) 
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The test sera and a positive and negative control sera are absorbed onto a plastic 
surface (Nunc microtitre plate). After blocking with a protein ( casein 1 % ) to prevent 
non-specific binding a detector monoclonal antibody (Moab) is added. Thereafter a 
conjugated species-specific antibody is used to detect the amount of Moab that adhered 
to the test and control sera antigens. Antibodies used are animal derived: mouse 
detector monoclonal antibody and goat conjugated antibodies. Horseradish peroxidase 
is used as the conjugating enzyme with orthophenylene diamine (OPD) as chromogen 
and hydrogen peroxidase as substrate. The amount of antibody captured by the coated 
antigen (test serum) is then determined spectrometrically. 
Inhibition ELISA: (Allotyping G3m(b1) 
No monoclonal antibody that is specific for G3m(b1) is available. The only Moab that 
includes G3m(b1) also reacts with u and u allotypes. The procedure was therefore 
adapted in that a known serum that contained the allotype G3m(b
1) but not u/v was 
used for coating the microtitre plates. The test serum is then mixed with the 
monoclonal antibody and allowed to react before plating. If the G3m(b
1) allotype was 
present in the test serum, the Moab is prevented from reacting with the coating serum. 
By adding a negative and positive control, inhibition could be confirmed. 
Capture ELISA: (lgGl, 2, 3 and 4) 
Commercially available monoclonal antibodies are absorbed onto the solid phase 
(microtitre wells). The positive control (in standard dilutions), negative control and 
test sera are then added. A conjugated goat anti-human antibody is then used for 
subclasses IgG2, IgG3 and IgG4. For IgGl a biotinylated human derived Moab is used 
with streptavidin. Omythine phenyladianime and horseradish peroxidase is again used 
as chromogen substrate to obtain a spectrometric reading. Quantitation is then done 
via the standard curve, constructed with each run. 
Km(l) Allotype 
The lack of a suitable monoclonal antibody against Km 1 meant that this assay could not 
be adapted to be discriminatory and used for analysis in this study. The only Kml 
monoclonal antibody (Moab) available is human derived. The other more commonly 
available goat derived anti-human Moab can be detected by an enzyme labelled mouse 
anti-goat antibody. We attempted to biotinylate the human derived antibody with a 
commercially available kit. This would allow streptavidin to be used as a conjugate. 
Three preparations were done but none performed adequately, with a high signal to 
background ratios due to non-specific binding. As a last resort immune-precipitation in 
agarose gel was attempted for the Kml antibody, but no precipitation lines were 
observed in four different dilutions. 
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3.2.3 Quantification: 
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Quantification is achieved by equating a known standard serum concentration with a 
specific optic density. 
Because of the availability of commercial and/or WHO standards exact quantitation 
could be achieved for G2m(n), Glm(t) and the four lgG subclasses. The method 
employed is through heterologous inter-polation from standard curves generated with 
each run. Parallelism of the test serum and standards were obtained (Goddard 1992). 
Semi quantification: 
The lack of available standards for the allotypes G lm(a), G3m(b
1) and G3m(g1) 
necessitated that these assays were semi-quantitative. 
Reference sera containing the allotypes in question and negative sera were obtained 
commercially. Test serum results could therefore be grouped into equal or greater than 
the positive sera, lesser or equal to negative sera, or had optic density levels between 
the positive and negative reference sera. 
These intermediate results represent individuals that are most likely heterozygous for 
the particular allotype. With the availability of myeloma proteins that are allotypic 
specific, accurate quantification can be done in certain research laboratories ( Ota et al 
1991, Oxelius 1993a). Using the technique ofimmunoprecipitation (Rautonen Net al 
1989) has established that heterozygosity gives quantitative differences in optical 
density. This study did not attempt to identify homo and heterozygocity for the 
allotypes tested. 
3.2.4 ELISA technique standardisation and control 
The following standardisation and method controls were undertaken according to 
McLaren et al (1981): 
a. Inter-assay variation and sensitivity: 
The inter-assay coefficient of variation was determined for the allotypes that 
could be accurately quantified (Glm(t) and G2m(n)). Inter-assay coefficient of 
variation never exceeded 15% (Glm(t) 14.1% and G2m(n) 14.0%). 
In the semi quantitative ELISA test (Glm(a); G3m(g1) and G3m(b
1) the use of 
positive and negative control sera on each plate confirmed the result as positive, 
negative or indeterminant (less than positive control, more than negative 
control). The indeterminant group was categorised further by adding control 
sera mixtures to each run. The positive control serum was mixed with the 
negative control serums in dilutions of 1:2, 1:4, and 1:20. This was done for 
Glm(a) and G3m(gl). All optical densities (OD) that were two standard 
deviations above the negative control sera were considered negative, those 
between the positive control and two standard deviations below the 1 :4 dilution 
was considered positive and the group that fell in between was reanalysed. If 
on a second evaluation the OD remained above the 1: 20 dilution of the positive 
sera the result was accepted as positive. 
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b. Specificity and optimisation of test conditions: 
Checkerboard analysis were used in preliminary runs of each allotype to 
determine optimal dilutions, coating times and temperatures. Only non-specific 
backgrounds (NSB) ofless than 10% of the signal obtained were accepted. 
Runs were repeated if NSB was more than 10%. As far as possible the same 
batch of enzyme labelled antibodies were used to minimise the variability of 
enzyme-substrate reactions. 
c. Standardisation between assays was achieved by using the same batch of 
reference sera for each allotype and the same procedure under the same 
wor~ng conditions. Most reactions took place at room temperature which was 
controlled between 18° and 22°C. 
Validation of allotyping by haemagglutination: 
The ELISA determination of Glm(t) and G2m(n) allotypes were validated earlier 
(Goddard 1994) by a WHO recognized reference laboratory: The Central Laboratory 
of the Netherlands Red Cross Blood Transfusion Service, Amsterdam. 
3.2.5 Statistical Analysis: 
Data was entered on a statistical program distributed by the Centre of Disease Control, 
Atlanta, USA(Epilnfo version 6) Analysis was performed by comparing 2 x2 tables by 
means of the Chi- square or Fisher exact tests. Non parametric data were calculated by 
applying Barlett's test for homogeneity and the Kruskal-Wallis H test. Due to the ever 
changing reference ranges (according to sex, age and race) for IgG (total) and 
subclasses the mean values were used. Multiples of the Mean Age Norm were then 
calculated and compared. Thus each ancestry cohort could be grouped together for 
comparisons.(see Table 4.5) 
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CHAPTER 4 
RESULTS 
4.1 CLINICAL DATA OF PATIENT COHORT 
In this section the proven TB cohort is compared with probable TB group to 
investigate the simalarities and important factors predisposing children to aquire 
pulmonary tuberculosis. 
4.1.1 Demographic data: 
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Thirty five children's serum samples with definite M tuberculosis either on direct 
microscopy and/or culture were used for allotype determination. The demographic 
data of these patients and 64 probable cases (organism negative) are depicted in Table 
4.1. 
TABLE 4.1:DEMOGRAPHIC DATA (Rounded off percentages in brackets) 
Race 
Mixed Ancestry 
Black 
Sex 
Male 
Female 
Age (months) 
Median 
Range 
Immunisations 
Complete 
BCG received 
Skin testing 
Tine > Grade I 
Mantoux > 10 mm 
TB contact positive 
Housing 
Shack 
Brick house 
Room/flat 
Other 
Unknown 
TB Confirmed 
(n = 35) 
15 (43) 
20 (57) 
20 (57) 
15 (43) 
40 
3-171 mths 
23 (65) 
25 (71) 
7 (20) 
28 (80) 
20 (57) 
14 (40) 
15 (43) 
3 (8.5) 
3 (8.5) 
TB Probable 
(n = 64) 
20 (31) 
44 (69) 
32 (50) 
32 (50) 
38 
6-164 mths 
54 (84) 
56 (88) 
21 (33) 
49 (77) 
23 (36) 
28 (44) 
20 (31) 
10 (16) 
5 (8) 
1 (1) 
Total 
(n = 99) 
35 
64 
52 
47 
39 
3-171 mths 
77 
81 
28 
77 
42 
35 
13 
7 
2 
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Table 4.1 continued: 
TB Confirmed TB Probable Total 
Overcrowding 
> 4 persons/room 9 (27) 12 (18) 21 
Income 
One parent employed 17 (49) 33 (52) 50 
Both parents employed 3 (8) 5 (8) 8 
Both unemployed 15 (43) 26 (40)' 41 
Caretaker-
Mother 18 (51) 41 (64) 59 
Family member 14 (40) 8 (12.5)* 22 
Creche/school 2 (6) 11 (17) 13 
Unknown 1 (3) 4 (6.5) 5 
• p: (Mantel Haenszel) 0.0017 
As expected the children came from an impoverished background wit
h overcrowded 
housing conditions. The TB proven group had less contact with med
ical services 
judged by completed immunisations (65%), than the TB probable group (84%). 
There were more male than female patients (ratio 1: 1. 3) and more Black than Mixed 
Ancestry children. The median age was 40 months (range 3-171 months). Most wer
e 
in the care of their mother ( 51 % ) but a larger number of proven TB group were in the
 
care of a family member (40%), than the probable TB group (12.5%). The reason for 
this is not clear. Fifty seven percent of the proven TB group had a po
sitive TB contact 
compared to only 36% of the probable TB group. 
There were however differances between the Black and Mixed Ances
try cohorts. 
Important differences concerning housing ( 61 % shacks versus only 9% in the Mixed 
Ancestry group) and contact with health services, as judged by immunisation 
coverage. Only 60% of the Black children were fully immunised where a
s 94% of the 
Mixed Ancestry children were fully immunised. Employment figures 
were about the 
same for the two race groups. One could therefore conclude that the
 Mixed Ancestry 
group is less socially deprived and has the opportunity to present them
selves earlier 
for diagnosis and therapy (Table 4.2). 
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TABLE 4.2:DEMOGRAPHIC DATA: BLACK VERSUS MIXED ANCESTRY 
(Rounded off percentages in brackets) 
Sex: 
Male 
Female 
Age (months) 
Median 
Range 
Immunisations 
Complete 
BCG received 
Skin testing 
Tine > Grade I 
Mantoux > 10mm 
Housing 
Shack 
Brick house 
Room/flat 
Other 
Unknown 
Overcrowding 
> 4 persons/room 
Income 
One parent employed 
Both parents employed 
Both unemployed 
Caretaker 
Mother 
Family member 
Creche/School 
Unknown 
Black 
(n = 64) 
36 (56) 
28 (44) 
42 
3-164 
44 (69) 
47 (73) 
14 (22) 
59 (92) 
39 (61) 
11 (17) 
6 (9) 
6 (9) 
2 (3) 
15 (23) 
35 (55) 
3 (5) 
26 (41) 
43 (67) 
13 (20) 
5 (8) 
3 (5) 
Mixed Ancestry p Value* 
(n = 35) 
16 (46) 
19 .(54) 
67 
5-171 
33 (94) p<0.01 
34 (97) p<0.01 
5 (14) 
2 (97) NS 
3 (9) p<0.001 
24 (69) P<0.001 
7 (20) NS 
0 (0) NS 
1 (3) 
6 (17) 
20 (57) 
4 (11) 
11 (31) NS 
16 (46) 
9 (26) 
3 (6) 
2 (6) 
* Yates corrected 
4.1.2 Disease Profile: 
The following symptoms were recorded on enrollment: coughing, loss of weight, loss 
of appetite, night sweats, shortness of breath, wheezing and fever. Of those with 
pulmonary tuberculosis nearly 85% presented with coughing, loss of appetite and 
fever. 
Physical signs recorded included: Height and weight measurements, signs of 
hypersensitivity, lymphadenopathy detailed chest findings, central nervous system and 
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abdominal findings. Hypersensitivity attributed to M tuberculosis was found in 5% 
and lymphadenopathy in 24%. 
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Those with definite proven M. tuberculosis did not differ in clinical signs at 
presentation from the probable TB group although chest X-ray findings were 
significantly different with the proven group showing more advanced disease as could 
be expected from the higher yield in microbiological positive results.(Table 4.3). 
TABLE 4.3 CHEST X-RAY FINDINGS: 
Primary TB 
Primary complex 
Lymphnodes 
Progressive primary 
Miliary 
Pleural 
Post primary 
Percentages in brackets 
TB Positive 
(n = 33) 
3 (9) 
2 (6) 
23 (70) 
7 (21) 
8 (24) 
4 (12) 
Probable TB 
(n = 64) 
18 (28) 
6 (9) 
35 (35) 
1 (2) 
22 (34) 
0 
p Values 
(Fischer exact) 
0.037 
0.603 
0.001 
0.308 
0.011 
In four children other systems apart from the respiratory were also affected by 
tuberculosis: 
Meningitis = 1 
Abdominal TB = 1 
Glandular TB = 1 
Bone TB 
Pericardial effusions 
4.1.3 Severity Score 
= 
0 
1 
The mean severity scores for children with proven TB and probable TB were 4. 94 and 
3.80 respectively. Due to the large standard deviation in each group this was not a 
significant finding (Table 4.4). 
TABLE 4.4: SEVERITY SCORE MEAN V ALOES 
PROVEN TB PROBABLE TB 
Mean Median SD Mean Median SD 
Age 1 1 1 1 
Hb 0.74 1 0.74 0.66 1 0.73 
CXR 1 1 0.48 0.59 1 0.53 
Albumin 0.94 1 0.75 0.69 1 0.65 
Height for weight 1.29 1 0.75 0.84 1 0.77 
Mean ( total score) 4.94 4 1. 79 3.80 3 1.99 
SD= standard de,iation 
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4.2 PATIENT COHORT 
4.2.1 IgG (total) and IgG subclasses 
The normal values used for comparison were obtained from a study done among the 
same population (Goddard et al 1992). Only proven cases were analysed. Due to ever 
changing normal ranges ( according to sex, race and age), the data obtained for this 
study is expressed as multiples of the mean value for the specific race and age 
categories (called multiples of the mean age norm or MMN). The mean values 
according to the specific race and age category ( called mean age norm or MAN) thus 
provided the basis for comparing the individual values. (Jable 4.5). 
TABLE 4.5: SUBCLASSES: PROVEN TUBERCULOSIS PATIENTS 
Mean Maximum Normal Range* Mean Multiples 
Age Of Mean 
Norm Age 
(gram/litre) Norms 
IgG Total 
All 22.875 45.730 14.288 1.634 
Black 23.521 31.720 7.121-28.387 14.778 1.644 
Mixed 22.013 45.730 5.179-26.046 13.682 1.533 
Ancestry 
IgGl 
All 19.913 40.930 12.342 1.625 
Black 20.770 29.590 6.997-27.019 13.347 1.570 
Mixed Ancestry: 
Male 20.691 40.930 5.411-19.564 11.047 1.834 
Female 17.089 22.850 5.241-24.560 10.964 1.581 
IgG2 
All 1.707 3.300 0.923 2.026 
Black 1.651 3.300 10.219-2.119 0.772 2.234 
Mixed Ancestry: 
Male 1.930 2.740 0.200-3.212 0.987 2.032 
Female 1.654 2.840 0.200-3.212 1.243 1.501 
IgG3 
All 0.938 2.440 0.772 1.645 
Black 0.835 1.7860 0.184-2.315 0.622 1.417 
Mixed Ancestry: 
Male 0.986 1.890 0.176-2.355 0.622 1.736 
Female 1.155 2.440 0.189-2.032 0.593 2.135 
IgG4 
All 0.322 0.920 0.174 2.001 
Black 0.291 0.920 0.004-0.840 0.173 2.046 
Mixed Ancestry: 
Male 0.343 0.740 0.002-0.830 0.196 1. 757 
Female 0.369 0.760 0.006-0.809 0.156 2.101 
* Reference: Goddard et al 1992 
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The mean values for both race groups were significantly higher than the reference 
ranges for IgG total and all four subclasses. This is best illustrated by the Multiples of 
Mean Age Norm (MMN), where the average MMN for IgG total was 1.634 (more 
than one and a halftimes elevated when compared to the reference mean value). 
The subclasses IgG2 and IgG4 showed highest elevation for the patient group as a 
whole. The IgG2 (Blacks) and the IgG3 (Mixed Ancestry females) subclasses were 
the most raised in each racial group. Black patients' mean MMN as a group was 
1. 817 and the Mixed Ancestry patient group was 1. 688 (no significant difference). 
There was no correlation between age and MMN values (data not depicted). 
There were too few numbers to analyse the effect of each allotype on the subclass 
values since each age group, race and sex group had it's own reference values. 
4.2.2 Allotypes 
When the two population groups with culture proven tuberculosis were compared, no 
significant differences could be found in the 5 allotypes measured (Table 4.6). 
Apparent differences between the two groups did not reach significance due to the 
small numbers analysed. 
TABLE 4.6: ALLOTYPES IN CHILDREN WITH PROVEN 
M TUBERCULOSIS (percentages positive in brackets) 
Allotype All Black Mixed Ancestry 
Glm(a) 
Glm(f 
G2m(n) 
G3m(gl) 
G3m(bl) 
(n = 35) 
35 
3 
2 
23 
31 
(100) 
(9) 
(6) 
(66) 
(86) 
4.3 CONTROL GROUP 
4.3.1 Allotypes 
(n = 20) 
20 
0 
0 
13 
17 
(n = 15) 
(100) 15 (100) 
(0) 3 (20) 
(0) 2 (13) 
(65) 10 (67) 
(85) 14 (93) 
The Black and Mixed Ancestry control groups differed significantly in that more of 
Mixed Ancestry persons were Glm(f) and G2m(n) positive. Adults and children did 
not differ in allotype frequency (Table 4.7). 
Only 51 Mixed Ancestry adults and 80 Black adults were tested for G3m(b 1 ). This 
was because the method used, inhibition ELISA, needed dilutions of 1: 50 and thus 
consumed reagents. Further analysis was not undertaken when it appeared that no 
significant differences were apparent between racial groups or the control and 
tuberculosis cohort. 
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TABLE 4.7: CONTROL GROUP: ALLOTYPES (percentages positive in brack
ets) 
* 
** 
Allotype 
Glm(a) 
Glm(t) 
G2m(n) 
G3m(g1) 
G3m b1 
p = 0.0018, 
p = 0.003, 
Black 
n=232 
232 (100) 
14 (6) 
11 (5) 
188 (97) 
47 92 
n=51 
OR3.30 
OR3.74 
Mixed 
Ancestry 
n= 211 
196 (92) 
120 (57)* 
92 (44)** 
197 (93) 
68 85 
n=80 
Black Mixed 
Ancest 
Adult Child Adult 
n = 173 n=59 n= 145 
173 (100) 59 (100) 132 (91) 
8 (5) 6 (10) 84 (58) 
9 (5) 2 (3) 65 (45) 
173 (100) 15 (71) 135 (93) 
43 92 74 84 
n=47 n=56 
4.4 PATIENT VERSUS CONTROL GROUP: ALLOTYPES 
Child 
n =67 
64 (96) 
36 (54) 
27 (41) 
62 (93) 
21 88 
n=24 
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The most striking difference was found in the Glrn(t), G2m(n) and G3m(gl) allotyp
es 
in the Mixed Ancestry population (Table 4.8). Children with TB had a significantly 
lower frequency of Glm(t), G2m(n) and G3m(gl) than the control group. This 
association was even stronger when the proven and probable TB chil
dren were 
analysed together. In the Black population the G3rn(gl) allotype was also found to 
be of a lower frequency in the children with proven TB (Table 4.8). 
TABLE 4.8:TB VERSUS CONTROL: ALLOTYPES (percentages positive) 
Allotype 
Glm(a) 
Glm(t) 
G2m(n) 
G3m(gl) 
G3m(bl) 
* 
20 
0 
0 
13 
17 
OR 20.35 
Proven TB 
(n=20) 
(100) 
(0) 
(0) 
(65) 
(85) 
Black Population 
Control 
(n=233) 
233 (100) 
15 (6) 
11 (5) 
189 (97) 
47 (92) 
(n=51) 
Mixed Ancestry Population 
Allotype 
Glm(a) 
Glm(t) 
G2m(n) 
G3m(gl) 
G3m(b1) 
Proven TB 
(n=15) 
15 
3 
2 
10 
14 
* Yates corrected 
NS = non significant 
(100) 
(20) 
(13) 
(67) 
(93) 
Control 
(n=211) 
203 (93) 
120 (57) 
92 (44) 
202 (96) 
68 (87) 
(n=80) 
p Value 
NS 
NS 
NS 
< 0.001 * 
NS 
p value 
NS 
0.01 
0.04 
0.001 
NS 
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4.5 HAPLOTYPES IN TB GROUP 
The five allotypes tested for in the proven TB group consisted of the following 
haplotypes: 
Hap lotype 1: 
Haplotype 2: 
Haplotype 3: 
Haplotype 4: 
Haplotype 5: 
Haplotype 6: 
Glm(a), G3m(bl), G3m(gl) 
Glm(a), Glm(t), G3m(bl), G3m(gl) 
Glm(a), G3m(bl) 
Glm(a), G3m(gl) 
Glm(a), Glm(t), G2m(n), G3m(bl) 
Glm(a), Glm(t), G2m(n), G3m(bl), G~m(gl) 
(n=l 7) 
(n=l) 
(n=ll) 
(n=4) 
(n=l) 
(n=l) 
The IgG subclass values were not distributed normally in each of the haplotypes 
studied, and therefore non-parametric statistics were used. 
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A weak significant difference between the mean values oflgG2 and IgG3 were found 
when those with versus those without haplotype 1 were compared ( p = 0.04, see 
Table 4.9). On comparing the two race groups with each other for haplotype 1, there 
was no differences in the mean values of any of the subclasses. 
There was no association between haplotypes and disease severity score ( data not 
shown). 
TABLE 4.9: HAPLOTYPE VERSUS MEAN SUBCLASS VALUES 
Haplotype Subclass (mean values) 
1 
3 
4 
Pos 
Neg 
Pos 
Neg 
Pos 
Neg 
IgGl 
12.086 
12.584 
13.019 
12.032 
13.342 
12.213 
G2 
0.753* 
1.083 
0.937 
0.916 
0.847 
0.932 
(Haplotypes 2, 5 and 6 excluded, one patient only in each haplotype) 
* Kruskal-Wallis H (non-parametric statistics used) p = 0.04 
G3 
0.557* 
0.671 
0.691 
0.581 
0.631 
0.163 
G4 
0.139 
0.207 
0.224 
0.151 
0.172 
0.174 
In the Black Race group with proven TB the absence of the haplotype 1 was a 
significant finding (p = 0.006, OR 4.67). This was not found in the Mixed Ancestry 
Race group. In none of the other haplotypes were any significant differences between 
the race groups or those with and without proven TB. 
4.6 DISEASE SEVERITY SCORE 
When the allotypes were compared with the disease severity score attained, no 
influence could be demonstrated (Table 4.10). 
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TABLE 4.10: ALLOTYPES AND DISEASE SEVERITY 
Median Severity Score* 
Proven TB cases 
Allotype Proven TB AIITB Black Mixed 
Ancestry 
Glm(a) Pos 5 (4.7) 5 (4.7) 5 (5.1) 5 (4.6) 
Neg none 4 (3.8) none none 
Glm(f) Pos 4 (4.0) 4 (4.2) none 3 (3.7) 
Neg 5 (4.9) 4 (4.2) 5 (5.0) 5 (4.8) . 
G2m(n) Pos 3 (3.0) 4 (4.0) none 5 4.8) 
Neg 5 (4.9) 5 (4.2) 5 (4.8) 3 (3.0) 
G3m(bl) Pos 5 (5.6) 5 (4.7) 5 (4.9) 5 (4.7) 
Neg 4 (4.8) 4 (4.2) 6 (6.5) 4 (4.0) 
G3m(gl) Pos 5 (5.4) 4 (4.2) 6 (5.7) 5 (5.1) 
Neg 4 (3.9) 3 (3.8) 4 (4.0) 4 (3.7) 
* Mean score in brackets 
4.7 SUMMARY OF IMPORTANT FINDINGS 
1. Mixed Ancestry children with proven tuberculosis expressed the Glm(f), 
G2m(n) and G3m(gl) allotypes less frequently. In Black children with proven 
tuberculosis, only G3m(gl) showed a similar association. This suggests that the 
absence of these lg allotypes is associated with an increased susceptibility to M 
tuberculosis infection. 
2. Within the allotypes tested no effect on IgG subclass levels in children with 
pulmonary tuberculosis could be shown due to small numbers per category. 
3. Disease severity was not associated with any change in allotype frequency. 
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CHAPTERS 
DISCUSSION AND CONCLUSION 
5.1 PATIENT SELECTION AND CHARACTERISTICS 
The patient selection in this study suffers from some bias in that only children 
presenting themselves to hospitals in the Cape Peninsula were considered. These 
children would therefore differ from a non-hospitalised pulmonary TB paediatric 
patient group in the following ways: 
1. More acute co-infections with viral or bacterial organisms 
11. More severe or complicated pulmonary TB 
m. Possibly better social status with sufficient resources to reach hospital. 
1v. Selection criteria which virtually excluded bone TB and TB meningitis. 
38 
The data presented suggests that the Mixed Ancestry population group is a more 
socially privileged group with greater access to health services when compared to the 
Black Ancestry group. (table 4.2). The much higher incidence (718: 100 000 see page 
16) is thus not easily explained on socio-economic factors alone. More research is 
needed to unravel this phenomena, but it suggests that other factors could be at play 
i.e. genetical influences. 
To confirm the similarities in under-privileged communities such as our patient 
cohort, two other studies of paediatric TB patients were considered (Table 5.1). The 
one study was purely community based (Ravensmead, RSA) and the Uganda study 
that was a hospital based study. 
The important differences between our study and those quoted are: 
1. the higher percentage of cavitating x-ray appearances. This may reflect that the 
more ill children present to hospital when compared to community treated 
tuberculosis and that possible differences in interpretation (medical officer 
versus radiologist) could influence the X-ray assessments. 
11. the high percentage of negative intradermal tuberculin tests in the community 
studies and the large number of suspected TB cases in the Uganda study 
illustrate the difficulties experienced in reaching a definite diagnosis in childhood 
tuberculosis. 
TABLE 5.1:COMPARISON OF DEMOGRAPHIC DATA 
Present Study Ravens mead* Uganda# 
(All TB cases) (Cape Town) 
n =99) (n - 124) (n = 210) 
Age 
<2 32% 6% All< 5 years 
2-5 44% 34% 
> 5 years 23% 20% 
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TABLE 5.1:COMPARISON OF DEMOGRAPHIC DATA (continued) 
Male:female 
Over crowding 
Unemployment 
CXR findings: 
Lymphadenopathy ( only} 
Pulm infiltrates 
Pleural/ cavitations 
Weight for age< 3rd% 
TB contact 
Skin testing 
Positive 
Negative 
Not done 
TB category (WHO) 
Suspected 
Probable 
Proven 
References: 
* Stoltz AP et al. 1990. 
# Miglion GB et al. 1992. 
Present Study 
(All TB cases) 
n =99) 
1.11 
21% 
42% 
8% 
49% 
30% 
36% 
43% 
Mantoux 
77% 
11% 
12% 
64% 
35% 
Ravensmead * 
(Cape Town) 
(n - 124) 
1.03 
74% 
26% 
40% 
53% 
Heaf 
16% 
34% 
27% 
20% 
72% 
18% 
Uganda# 
(n = 210) 
17% 
19% 
11% 
53% 
Mantoux 
37% 
63% 
Nil 
74% 
10% 
15% 
All three studies underline the fact that young children in poverty related settings are 
particularly prone to develop tuberculosis. Since our study's cohort may have 
differences in social and economic background (Table 4.1) it is possible than the case 
selection ( of self-presenting hospital admissions) provided bias by selecting a more 
under-privileged group with a higher incidence of the disease. The majority of our 
cohort is of Black Ancestry which is due to the predominance of this culture group in 
the suburbs providing most of the admissions to the three teaching hospitals. The 
child adult ratio where roughly the same for each of the population groups ( 1 : 3 see 
table 5.2) The slightly more males in the proven and probable patient cohort is also 
found in the Ravensmead study but has not been adequatedly explained. 
5.2 CONTROL GROUP SELECTION 
Due to the difficulties of obtaining consent and case matched controls in a paediatric 
population, controls were selected from other readily available serum samples. This 
could lead to selection bias with genetic subgroups disproportionally represented. As 
pointed out earlier (Chapter 2.3.2) the population genetic drift has most likely 
remained constant over the last 40 years. There is no data to substantiate this but 
demographic patterns and population ratios have not changed significantly, except for 
an increased proportion of Xhosa speaking Blacks migrating to the Western Cape 
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<14yrs 
since 1980. The origin of the Black population in the Western Cape has
 remained the 
same (Eastern Cape region, formerly Transkei and Ciskei) (Table 5.2). 
The prevalence rate for pulmonary TB among those of Mixed Ancestry 
in the 
Western Cape region was estimated in 1992 to be 704:100 000 (Eggers et al 1994). 
There is thus a possibility that some of the control group were infected 
with 
pulmonary tuberculosis. The absence of significant weight loss and pers
istent 
coughing on direct questioning ( all adult and child controls) supplemented with a 
normal clinical examination (in all children and Black Ancestry adult controls) makes 
this less likely. 
TABLE 5.2:POPULATION STATISTICS- WESTERN CAPE REGI
ON 
Total Population TB Incidence 
Year Black Mixed Ancestry Black Mixe
d Ancestry 
(Rounded off to thousands) (per 100000) 
1950 60 297 200 (202)* 445 (414) 
1960 75 417 410 (428) 522 (526) 
1970 108 606 288 (334) 290 (305) 
1980 183 775 212 (215) 315 (316) 
1991 539 1991 198 (191) 709 (652) 
1995 640 2215 no data available 
1991 146 (26%) 645(32%) no data available 
* Values in brackets are the National average figures 
References: Tuberculosis Control Programme - 1992 
Epidemiological Comments Vol 21(1); 1994 
Population Census 1950, 1970, 1980 
CSSD Report: Provincial Statistics 1994 (Part I), Printed by: The Government Printer, P
retoria 
5.3 IgG AND IgG SUBCLASSES 
The mean values of total IgG and the four subclasses were grossly eleva
ted. This is in 
keeping with other chronic infections/inflammatory conditions such as h
istoplasmosis 
and leprae and has previously been described in tuberculosis (Lenzini et al 1997; 
Kaplan et al 1980). 
The subclasses with the highest elevation were IgG2 and IgG4 ( and IgG3 in the 
Mixed Ancestry female group). Specific IgG subclass stimulation in a disease like M 
tuberculosis is due to multiple protein and polysaccharide antigens. The
re is evidence 
that certain protein antigens are more specific (ea: 32-kDa protein) than non-protein 
antigens (Harboe et al 1992). A number of other factors influence IgG subclass 
production including age, sex and allotype expression. Also it has been
 claimed that 
protein antigens influence IgG 1 production most (Jefferis et al 1990). We could not 
find any influence of age, sex or allotype expression on these subclass v
alues. 
Because of these multiple factors no firm conclusion can be drawn from
 the finding of 
IgG2 and IgG4 predominance in our study. 
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Further studies utilizing mycobacterium specific antigen detection and possibly 
isolated B-cells from disease patients might elucidate the significance of lgG subclass 
production. 
5.4 SEVERITY SCORE 
A disease severity score is a useful tool for monitoring disease response to therapy. 
Most scoring systems focus on one anatomical system and its' related symptoms and 
signs. In the severity score used in this study a multisystem approach was selected. 
Nutrition, as evaluated by height for body mass, respiratory involvement as reflected 
on chest x-ray, liver metabolism (and nutrition) as reflec.ted by albumin values and 
haemopoiesis as depicted by haemoglobin concentration. 
One other study on children with tuberculosis utilizing a severity score could be found 
(Tidjani et al 1986). This scoring system included symptoms and signs of lung 
disease, chest x-ray findings, sputum analysis for M tuberculosis and response to 
therapy. In the above mentioned study the scoring system proved useful 
retrospectively in aiding TB diagnosis. Our scoring system could not differentiate 
between bacterial proven and non-proven cases. Age and allotype expression and 
subclass levels did not influence the severity score either. Since the study did not 
follow patients through till x-ray resolution, the score could not be validated against 
outcome. 
5.5 ALLOTYPES 
A comparison of allotypes frequency in the control groups with other studies in the 
same populations is shown in Table 5.3. 
TABLE 5.3: COMPARISON OF ALLOTYPES IN SIMILAR SOUTH AFRICAN 
POPULATIONS 
Mixed Ancestry Blacks 
Allotype 
Glm(a) 
Glm(t) 
G2m(n) 
G3m(g1) 
G3m(b1) 
Present Goddard Jenkins Steinberg Present Goddard Jenkins 
Study 1994 1970 1975/81 Study 1994 1970 
99.5% 95% 100% 100% 100% 
57% 62% 55% 8% 6% 2% 1.4% 
44% 34% 5% 3% 
95% 63% 97% 
87% 87% 61% 92% 86% 
There is a good correlation between the studies quoted which strengthens the claim of 
representibility of the control groups used. 
5.6 ALLOTYPES IN M TUBERCULOSIS 
Within the Black Ancestry cohort only G3m(g I) allotype showed an association with 
pulmonary tuberculosis. In the TB proven group of 20 children, 13 (65%) had 
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G3m(gl) allotype. In the control group 97% had the allotype. If however only 
children of the Black Ancestry group ( cohort and controls) are compared this 
difference disappears. These child controls were all of one age group (8-12 months), 
and had (presumedly) a much lower IgG3 level than the adults. (Goddard 1994) It is 
thus possible that due to the high backgrounds in the ELISA used (two SD above 
negative gave a OD of 1.402), the test was not sensitive enough for decreased epitope 
frequency in the low IgG3 subclass concentrations in the child sera. In the M
ixed 
Ancestry child controls the mean age was 3 5 months and here the significant 
differences remained if only children were compared. (Data not shown) Another 
possibility is that the small Black Ancestry child control group (only 21controls) 
showed heterozygosity in their expression of the G3m(gl) allotype. This could also 
lead to spureous negative results. In conclusion: the absence of the G3m(gl) allotype 
was associated with pulmonary tuberculosis in the Mixed and Black Ancestr
y groups 
(with some reservations). Among the Mixed Ancestry group there was a strong 
association (p = 0.01 and 0.04) of pulmonary tuberculosis with the absence of G2m(n) 
and Glm(f). 
The findings from this study differs from the three other studies on TB and A
llotypes. 
(Table 5.4) 
TABLE 5.4: ALLOTYPES IN M. TUBERCULOSIS 
Population Studied 
Allotype Indonesia* Moscow# Tuvinia+ 
Glm(a) No difference Increased Increased 
Glm(f) No difference Increased Increased 
Glm(x) Decreased Decreased Increased 
G2m(n) Not done Not done Not done 
G3m(g1) Decreased Not done Not done 
G3m(b1) No difference Not done Not done 
Km(l) Decreased Not done Not done 
References: * Gibson et al 1987 
+ Matrakshin 1993 
# Chukanova et al 1994 
Cape Town 
No difference 
Decreased 
Not done 
Decreased 
Decreased 
No difference 
Not done 
Some obvious differences can be noted: Increased Glm(f) in the Russian and Tuvinian 
patients and decreased in the present study. Also the G lm(x) gave similar discordant 
findings. All four studies damed to have selected cultural (and thus genetically) 
similar cohorts as their patient group. We could state that no allotype (or haplotype) 
is consistently associated with pulmonary tuberculosis or for that matter any
 other 
disease in different populations groups as is depicted in table 5.5. Genetic 
susceptibility associated with a allotypic phenotype is then rather dependend
 on other 
mechanisms / modulation. Consideration should be given whether allotypes a
re merely 
genetic markers for some more fundamental abnormality (?receptor gene expression) 
in handling infectious agents. Recently Saha et al ( 1994) showed that defective T cell 
mediated responses to mycobacterial antigens in the murine model was due t
o an 
inability of the macrophage cells to deliver appropriate co-stimulatory signal
s to the 
T-helper cells. Could it be that allotypic expression is associated with macro
phage 
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innate resistance? Evidence that antibodies influence macrophage function is scanty 
but reported by Forget (1976) in murine in vitro models. However we could not 
demonstrate any allotypes influences on antibody levels in PTB in our cohort of 
children. 
TABLE 5.5: DISEASE ASSOCIATIONS WITH ALLOTYPES Glm(f) AND G2m(n) 
Reference Age Race Disease Allotype 
G2m(n) Glm(f) 
Goddard Child Mixed H. influenzae Absent No difference 
Ancestry 
1994 Black Meningitis No difference No difference 
Granoff et al Child Black H. influenzae No difference Not done 
1984 White Meningitis No difference Not done 
Demaine et al Adult White Idiopathic 
1984 Membranous Not done Decreased 
Nephropathy 
Ambrosino et al Child White H. influenzae Absent Not done 
1985 
Takala et al Child White H. influenzae No difference Not done 
1991 
5.7 FURTHER RESEARCH A VENUES 
The finding that a genetic difference in immunoglobulin allotypic markers is associated 
with M. tuberculosis disease in Mixed Ancestry and Black children indicates that 
further research into the genetic related pathogenic mechanism(s) in tuberculosis 
could be profitable. A study of lymphocyte proliferation, macrophage killing ability 
and other functional studies, correlated with immunoglobulin allotype expression 
could provide useful information in this regard. 
Allotype expression should be correlated with levels of subclass specific M. 
tuberculosis antibody production to elucidate possible mechanisms and changes in the 
humoral response to M tuberculosis antigens which may indicate a role for antibody 
production in recovery or protection from M. tuberculosis. If cytokine patterns could 
be determined from in vitro stimulated T- and B-cells in the examined group, the 
effect of T-helper cell (Th 1 or Th2) activity could be better documented. 
5.8 FINAL CONCLUSION 
There is a clear difference in G2m(n), Glm(f) and G3m(g1) allotype ( Mixed 
Ancestry) and less so in G3m(g1) ( Black race group) expression between controls 
and children with active tuberculosis. This support the hypothesis of genetic 
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susceptibility in tuberculosis. The very high incidence of PTB in the Mixed ancestry 
population group might well be related to a genetic determined increased 
susceptibility to Mycobacterium tuberculosis. No influence of Allotypes on IgG 
Subclasses levels in PTB could be shown due to the small numbers in each group. 
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APPENDIX 1 
Glm(a) ALLOTYPE ELISA 
Reagents: 
1. a. Stock glycine buffer: 0.05 M 
Adjust pH to 2. 5 with HCl. 
Working solution: 
2. 
3. 
b. 
Glycine/Tris Buffer (pH 7.0 - 7.5) 
Add solid Tris to stock glycine buffer until pH is between 7. 0 - 7. 5 
Tris Buffered Saline (TBS): 0.2 M Tris, 0.15 M NaCl 
NaCl 9.0·gm 
Tris 2.42 gm 
Add distilled H20 750 ml. Adjust pH to 7.5 using IN HCl. Make up to I litre with 
distilled H20. 
Blocking solution: 1% Casein in 0.01 M Tris, 0.15 M NaCl 
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Dissolve 9 g NaCl, 1.211 g Tris and IO g Casein into I litre of distilled water. Stir until 
well dissolved. 
4. Monoclonal antibody 
R2102 (1 ml lyphilized serum), CLB (Central Laboratory of the Netherlands, Red 
Cross Blood Transfusion Service) diluted 1/1000 in 1/10 blocker in TBS. 
5. Conjugate: 
Cappel HRPO goat anti-mouse (gamma chain specific) diluted 1/1000 in 1/10 Blocker 
in TBS. 
6. OPD: 
Dilute powder with citrate buffer-+ 2.5 mg/ml. For two plates use at least 8 mg 
powder. 
8 mg -+20 ml citrate buffer. Immediately before use add H20 2 I µI/ml (e.g Total 
volume = 20 mls, then add 20 µl H202) 
7. Citrate Buffer (0.1 M) 
Solution A: Citric acid= 4.2 g/200 ml 
Solution B: Sodium citrate= 5.888 g/200 ml 
Add 20.5 ml solution A to 29.5 ml solution B 
Adjust pH to 5.0 with 4 M NaOH. Make up to 100 ml with distilled H20. 
8. 2N H2S04 
5 3. 3 ml/litre = 2N 
Method: 
Reference sera: 
Rl 113 (+ve control diluted 1/10000 in glycine/Tris buffer) 
RI 117 (-ve control diluted 1/10000 glycine/Tris buffer) 
Mixed sera: RI 113 into RI 117 to contain 50%; 20% and 5% of RI 113. 
Patient sera: 
1/10000 dilutions with glycine/Tris buffer 
Serum blanks: 
Glycine/Tris buffer. 
1. Coat flat bottomed microtitre plates with 100 µl of reference sera, patient sera an
d 
glycine/Tris buffer respectively for test and blank. Incubate for 30 minutes at room 
temperature. 
2. Wash with TBS/0.01% Tween 20. 
3. Block overnight at 4°C with 1% casein. 
4. Wash 2x TBS/0.01% Tween. 
5. Add 100 µI/well Moab diluted at 1/1000 in 1/10 blocker. Leave two rows as blan
ks 
(1/10 Blocker). 
6. Wash 3x TBS/0.01% Tween. 
7. Add 100 µI/well conjugate (1/1000). Incubate 30 minutes at room temperature. 
8. Wash 5x TBS/Tween 0.01%. 
9. Add 100 µI/well OPD/H202. 
10. Stop reaction 50 µl/well 2N H2S04. 
11. Read at 492 nm. 
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APPENDIX 2 
Glm(t) ALLOTYPE ELISA 
Reagents: 
l. a. Stock glycine buffer: 0.05 M 
3. 7 5 g glycine/litre 
2. 
b. 
Adjust pH to 2.5 with HCl. Make up to l litre with distilled H20. 
Working solution: 
Glycine/Tris Buffer (pH 7.0 - 7.5) 
Add solid Tris to stock glycine buffer until pH is between 7.0 - 7.5 
Tris Buffer~d Saline (TBS): 0.02 M Tris, 0.15 M NaCl 
NaCl 9.0gm 
Tris 2.42 gm 
Add distilled H20 750 ml. Adjust pH to 7.5 using IN HCl. Make up to 1 litre with 
distilled H20. 
3. Blocker: 2% BSA/0.05% Tween 20 
For 2 plates: 1.2 gm BSA. Add to 60 ml TBS. Add 30 µl Tween 20 and stir for 5 
mins or until BSA has dissolved. 
4. Monoclonal Antibody: 
Sigma anti IgGl m(t) 
For two plates: Dilute 1/1500 i.e. 11 µ1 anti Glm(t) in 16.5 ml 1/10 blocker* 
5. Conjugate: Cappel goat anti mouse IgG (gamma-chain specific) 
Dilute 1/1500 with 1/10 blocker 
6. OPD: Dilute powder with citrate buffer~ 2.5 mg/ml. For two plates use at least 8 
mg powder. 
8 mg~ 20 ml citrate buffer. Immediately before use add H202 1 µ1/ml (i.e. Total 
volume = 20 mls, then add 20 µ1 H202) 
7. Citrate Buffer (0.1 M) 
Solution A: Citric acid= 4.2 g/200 ml 
Solution B: Sodium citrate= 5.888 g/200 ml 
Add 20.5 ml solution A to 29.5 ml solution B 
Adjust pH to 5.0 with 4 M NaOH. Make up to 100 ml with distilled H20. 
8. 2NH2S04 
53.3 ml/litre= 2N 
*1/10 blocker: Dilute 2% BSN0.05% Tween, 1/10 with TBS 
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Method: 
Standard curve: Dilute reference serum Rl 110 in glycine/Tris buffer - 1/500; 1/1000; 
1/2500; 
1/5000; 1/7500; 1/10000; 1/15000; 1/25000 and 1/50000. 
Ref sera: Rl 117 ( + ve control) dilute 1/10000 in glycine/Tris buffer 
Rl 113 (- ve control) dilute 1/10000 in glycine/Tris buffer 
Patient sera: Dilute 1/10000 in Glycine/Tris buffer 
Serum Blank: Glycine/Tris buffer. 
I. Add 100 µl standard curve dilutions, serum blank, reference sera and patient s
era to 
plate. Incubate 30' at room temperature. 
2. Wash plates lx with TBS/0.01 % Tween 20. 
3. Add 250 µl/well 2% BSN0.05% Tween (Blocker). Incubate 30' at room temperature. 
4. Wash plates 2x with TBS/0.01% Tween. 
5. Add 100 µI/well. MoAb - anti Glm(f) 1/1500 to rows A-C and E-G. Add 100 µI/well 
1/10 blocker to rows D and H. Incubate 30' at room temperature. 
6. Wash plates 4x with TBS/0.01% Tween. 
7. Add conjugate 100 µI/well - anti mouse GAM conjugate 1/1500. Incubate 30' at room 
temperature. 
8. Wash plates 5x with TBS/0.01% Tween. 
9. Add 100 µI/well OPD/lh02. Incubate 15' at room temperature. 
10. Stop reaction by adding 50 µl/well 2N H2S04. 
11. Read at 492 nm. 
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APPEND1X3 
G2m(n) ALLOTYPE ELISA 
Reagents: 
1. a. Stock glycine buffer: 0.05 M 
3. 7 5 g glycine/litre 
2. 
3. 
4. 
b. 
Adjust pH to 2.5 with HCl. Make up to I litre with distilled H20. 
Working solution: Glycine/Tris Buffer (pH 7.0 - 7.5) 
Add solid Tris to stock glycine buffer until pH is between 7.0 - 7.5 
Tris Buffered Saline (TBS): 0.01 M Tris, 0.15 M NaCl . 
NaCl 9.0 gm 
Tris 2.42 gm 
Add distilled H20 ~750 ml. Adjust pH to 7.5 using IN HCL Make up to I litre with 
distilled H20. 
Blocker: 2% BSN0.05% Tween 20 
For 2 plates: 1.2 gm BSA. Add to 60 ml TBS. 
Add 30 µl Tween 20 and stir for 5 mins or until BSA has dissolved. 
Monoclonal Antibody: 
Sigma anti IgG2m(n) 
For two plates: Dilute 1/10000 
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5 µl + 495 µl 1/10 blocker* (1/100) then take 160 µl of 1/100 and add to 14.4 mis 1/10 
blocker. 
5. Conjugate: Cappel goat anti mouse IgG (gamma-chain specific) 
Dilute 1/1500 with 1/10 blocker 
6. OPD: Dilute powder with citrate buffer~ 2.5 mg/ml. 
For two plates use at least 8 mg powder. 
8 mg~ 20 ml citrate buffer. Just before use add H202 I µl/ml (i.e. Total volume= 20 
mis, then add 20 µl H202) 
7. Citrate Buffer (0.1 M) 
Solution A: Citric acid= 4.2 g/200 ml 
Solution B: Sodium citrate= 5.888 g/200 ml 
Add 20.5 ml solution A to 29.5 ml solution B 
pH to 5.0 with 4 M NaOH. Make up to 100 ml with distilled H20. 
8. 2NH2S04 
53.3 ml/litre= 2N 
9. Standard curve: Use pooled AB serum 
*1/10 Blocker: Dilute 2% BSA (0.05% Tween 20) 
.-IPPF.\'DL\'F.'i' 
Method: 
Standard curve: Dilute pooled AB serum in glycine/Tris buffer - 1/2000; 1/4000; 1/6000; 
1/8000; 1/10000; 1/15000 1/20000; 1/30000; 1/50000. 
Ref sera: RI 110 (+ ve control) dilute 1/15000 in glycine/Tris buffer 
RI 113 (- ve control) dilute 1/15000 in glycine/Tris buffer 
Patient sera: Dilute 1 / 15000 in Glycine/Tris buffer 
Serum Blank: Glycine/Tris buffer 
1. Add 100 µl standard curve dilutions, serum blank, reference sera and patient sera to 
plate. Incubate 30' at room temperature. 
2. Wash plates Ix with TBS/0.01% Tween 20. 
3. Add 250 µ1/well 2% BSA/0.05% Tween (Blocker). 
Incubate 30' at room temperature. 
4. Wash plates 2x with TBS/0.01% Tween. 
5. Add 100 µI/well. Moab - anti G2m(n) 1/10000 to rows A-C and E-G. 
Add 100 µl/well 1/10 blocker to rows D and H. Incubate 30' at room temperature. 
6. Wash plates 4x with TBS/0.01% Tween. 
7. Add conjugate 100 µI/well - Cappel goat anti mouse IgG (gamma-chain specific) 
1/1500. Incubate 30' at room temperature. 
8. Wash plates 5x with TBS/0.01 % Tween. 
9. Add 100 µI/well OPD/H202. Incubate 15' at room temperature. 
10. Stop reaction by adding 50 µl/well 2N H2S04. 
11. Read at 492 nm 
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APPEND1X4 
G3m(gl) ALLOTYPE ELISA 
Reagents: 
1. a. Stock glycine buffer: 0.05 M 
3. 7 5 g glycine/litre 
2. 
b. 
Add distilled H20 (900 ml) 
Adjust pH to 2.5 with HCl. Make up to 1 litre with distilled H20. 
Working solution: 
Glycine/Tris Buffet: (pH 7.0 - 7.5) 
Add solid Tris to stock glycine buffer until pH is between 7.0 - 7.5 
Tris Buffered Saline (TBS), 0.02 M Tris, 0.15 M NaCl 
NaCl 9.0 gm 
Tris 2.42 gm 
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Add distilled H20 ~750 ml. Adjust pH to 7.5 using IN HCl. Make up to 1 litre with 
distilled H20. 
3 Blocker: 1 % casein/0.01 % Tween 20 in 001 M Tris, 0.15 M NaCl 
Dissolve 9 g NaCl, 1.211 g Tris and 10 g Casein into 1 litre of distilled water. Stir until 
completely dissolved. 
4. Monoclonal antibody: 
R2005 diluted 1/250 with 1/10 blocker** 
5. Conjugate: Cappel goat anti mouse IgG (gamma chain specific), for use dilute 1/1000 
in 1/10 blocker. 
6. OPD: Dilute powder with citrate buffer 2.5 ml/mg. For two plates use at least 8 mg 
powder. 
8 mg~ 20 ml citrate buffer. Immediately before use add H202 1 µl/ml (i.e. Total 
volume = 20 mls, then add 20 µ1 H202) 
7. Citrate Buffer (0.1 M) 
Solution A: Citric acid= 4.2 g/200 ml 
Solution B: Sodium citrate= 5.888 g/200 ml 
Add 20.5 ml solution A to 29.5 ml solution B 
Adjust pH to 5.0 with 4 M NaOH. Make up to 100 ml with distilled H20. 
8. 2NH2S04 
53.3 ml/litre= 2N 
**1/10 Blocker: Dilute 1% Casein with TBS 
Al'l'F\IJL\}'S 
Method: 
Reference Sera: 
Rl 113 (+ve control) dilute 1/30 in glycine/Tris buffer 
Rl 117 (-ve control) dilute 1/30 glycine/Tris buffer 
Mixtures ofRl 113 and Rl 117: to contain 50%; 20% and 5% ofRl 113. 
Patient serum diluted 1/30 in glycine/tris buffer 
Serum Blank: glycine/tris buffer 
1. Coat a flat bottomed microtitre plate. Add 100 µl of reference sera and test sera and 
incubate for 90 min at 3 7°C. Add 10 µl of glycine/Tris to blank wells. Add mixtures of 
reference sera. 
2. Wash lx with TBS/0.01% Tween 20. 
3. Block with·1% casein overnight at 4°C. 
4. Wash 3x with TBS/0.01% Tween 20. 
5. Add 100 µl/well of Moab. Incubate for 90 min at room temperature. 
6. Wash 4x with TBS/0.01% Tween 20. 
7. Add conjugate 100 µl/well. Incubate 30 min at room temperature. 
8. Wash 5x with TBS/0.01% Tween 20. 
9. Add 100 µl/well OPD/H202. Incubate 15 min at room temperature. 
10. Stop reaction with 50 µl/well 2N H2S04. 
11. Read at 492 run. 
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APPENDIX5 
G3m(b 1) ALLOTYPE ELISA 
Reagents: 
1. a. Stock glycine buffer: 0.05 m 
3. 7 5 g glycine/litre 
2. 
b. 
Adjust pH to 2.5 with HCl. Make up to 1 litre with distilled H20. 
Working solution: 
Glycine/Tris Buffer (pH 7.0 - 7.5) 
Add solid Tris to stock glycine buffer until pH is between 7.0 - 7.5 
Tris Buffered Saline (TBS), 0.02 M Tris, 0.15 M NaCl 
NaCl 9.0 gm 
Tris 2.42 gm 
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Add distilled H20 ~ 750 ml. Adjust pH to 7.5 using IN HCl. Make up to 1 litre with 
distilled H20. 
3. Blocker: 1% casein/0.01% Tween 20, 0.01 M Tris, 0.15 MNaCl 
Dissolve 9 g NaCl with 1.211 g Tris and 10 g casein into 1 litre of distilled water until 
dissolved. 
4. Coating serum: 
Rl 110 (1ml lypohilized serum). Central Laboratory, Netherlands Blood Transfusion 
Service. Serum contains Glm(a,t); G3m(b0, bl, b3, b4, b5, u, v) 
5. Monoclonal antibody: 
R2007 (1 ml lyophilized serum) 
Antiserum against: G3m(bl/u) dilute 1/2500 in 1/10 blocker 
6. Conjugate: Cappel goat anti mouse IgG conjugated to horse radish peroxidase. Dilute 
1/1000 with 1/10 blocker. 
7. OPD: Dilute powder with citrate buffer~ 2.5 ml/mg. For two plates use at least 8 
mg powder. 
8 mg~ 20 ml citrate buffer. Just before use add H202 1 µl/ml (i.e. Total volume= 20 
mls, then add 20 µl H202) 
8. Citrate Buffer (0.1 M) 
Solution A: Citric acid= 4.2 g/200 ml 
Solution B: Sodium citrate= 5.888 g/200 ml 
Add 20.5 ml solution A to 29.5 ml solution B 
Adjust pH to 5.0 with 4 M NaOH. Make up to 100 ml with distilled H20. 
9. 2N H2S04 
53.3 ml/litre= 2N 
. l f'PF\D/.\ F,'i 
Method: 
Patient sera: diluted 1/2500 in glycine/Tris 
Reference sera: 
Rl 110 (coating serum) dilute 1/1000 in glycine/Tris buffer 
Rl 117 (+ve control) dilute 1/2500 in 1/10 blocker. Mix with equal volumes of Moab 
Rl 113 (-ve control) dilute 1/2500 in 1/10 blocker. Mix with equal volumes of Moab. 
1. Coat microtitre (flat bottomed wells) plates with 100 µl ofRl 110. Blank wells are 
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filled with Glycine/Tris buffer. Incubate at 37°C for 30 min. Duplicates for each sera and one 
blank well is thus prepared. 
2. Wash plates Ix with TBS/0.01% Tween 20. 
3. Prepare dilutions of reference, patient and Moab sera mixtures. Add equal volumes and 
allow to react in shaking waterbath at 37°C for 45 minutes. 
4. Coat wells with 100 µI of sera mixtures. The two reference sera wells are prepared 
with duplicate sera and Moab mixture, duplicate sera alone and duplicate Moab alone. 
Incubate for 30 min at room temperature. 
5. Wash 3x with TBS/ 0.01% Tween. 
6. Add 100 µl of conjugate and incubate 30 min at room temperature. 
7. Wash 5x with TBS/Tween (0.01 %). 
8. Add 100 µI/well of OPD1H202. Incubate 15 min at room temperature in the dark. 
9. Stop reaction by adding 50 µl/well 2N H2S04. 
10. Read at 492 nm. 
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APPENDIX6 
VITAMIN A IN TB STUDY 
FIRST QUESTIONNAIRE 
identification 
No Name 
Hosp_ Hospspec 
HospNorxh HospNonsh ~~~~ 
DOB Age~-
Dafteradm DofTBRx 
Random CatTBDx 
Ifnottbwhatwasitthen? 
housing 
Type -
Elec 
Rooms 
Water 
Adults 
Transkei 
family 
Mmarried 
Sincome 
Deare 
Sibs 
irmnunizations 
Mempl _ 
Income 
PosPt 
Fempl _ 
Race Sex 
Ward 
HospNobch ~~~ 
DAdmtostudy 
DofADrec 
InclDstudy _ 
Child 
Complete_ 
nutrition 
BCGnodos Measdurtudy _ 
BWT 
BFED 
ADFF 
tbhistory 
ContAd 
Proph 
LOA 
LOW 
RWT 
NSweats 
Cough_ 
Wheeze 
SOB 
Fever 
Rill 
RRTI 
PITB 
RANTIB 
Size 
BFPer 
Conteh 
LOAPer 
LOWPer 
NSPer 
CPer 
WhPer 
SOBPer 
FPer 
Screened 
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TBHxadd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
PrevHx.~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-
Developm 
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SECOND QUESTIONNAIRE 
Study number 
Name 
clinical examination 
WeeksRx6w WeeksRx3rn WeeksRx6rn 
WTPr WT6w WT3m WT6m __ 
HTPr HT6w HT3m HT6m 
HCPr HC6w HC3m HC6m __ 
TnorPr T6w T3m T6m 
PalPr Pal6w Pal3m Pal6m_ 
OedPr Oed6w _ Oed3rn Oed6m_ 
MalPr Mal6w Mal3rn Mal6m_ 
ECPr EC6w EC3m EC6m_ 
RicPr Ric6w Ric3m Ric6m_ 
Ricadd 
FPr F6w F3m F6m _ 
ENPr EN6w EN3m EN6m_ 
LnPr Ln6w Ln3m Ln6m_ 
LaPr La6w La3m La6m_ 
LiPr Li6w Li3m Li6m_ 
CLPr CL6w CL3m CL6m_ 
CYPr CY6w CY3m CY6m_ 
BCGscPr BCGsc6w BCGsc3rn BCGsc6m_ 
resp 
RnorPr Rnor6w Rnor3rn Rnor6m_ 
RrPr Rr6w _ Rr3m Rr6m_ 
RECPr REC6w REC3m REC6m_ 
DecMMPr DecMM6w DecMM3m DecMM6m_ 
DulLUPr DulLU6w Du1LU3m Du1LU6m_ 
DulLMPr DulLM6w DulLM3m Du1LM6m_ 
DulLLPr DulLL6w DulLL3m DulLL6m_ 
DulRUPr DulRU6w DulRU3m DulRU6m_ 
DulRMPr DulRM6w DulRM3m DulRM6m_ 
DulRLPr DulRL6w DulRL3m DulRL6m_ 
DecAELUPr DecAELU6w DecAELU3m DecAELU6m 
DecAELMPr DecAELM6w DecAELM3rn DecAELM6m _ 
DecAELLPr DecAELL6w DecAELL3m DecAELL6rn 
DecAERUPr DecAERU6w DecAERU3rn DecAERU6m 
DecAERMPr DecAERM6w DecAERM3rn DecAERM6rn 
DecAERLPr DecAERL6w DecAERL3rn DecAERL6m 
BrbrLUPr BrbrLU6w BrbrLU3m BrbrLU6m 
BrbrLMPr BrbrLM6w BrbrLM3m BrbrLM6rn 
BrbrLLPr BrbrLL6w BrbrLL3rn BrbrLL6m 
BrbrRUPr BrbrRU6w BrbrRU3rn BrbrRU6rn 
BrbrRMPr BrbrRM6w BrbrRM3m BrbrRM6m 
BrbrRLPr BrbrRL6w BrbrRL3rn BrbrRL6rn 
CrLUPr CrLU6w CrLU3rn CrLU6rn_ 
CrLMPr CrLM6w CrLM3m CrLM6m_ 
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CrLLPr CrLL6w CrLL3m CrLL6m_ 
CrRUPr CrRU6w CrRU3m CrRU6m_ 
CrRMPr CrRM6w CrRM3m CrRM6m_ 
CrRLPr CrRL6w CrRL3m CrRL6m_ 
IStPR ISt6W ISt3M ISt6M_ 
EStPr ESt6w ESt3m ESt6m_ 
EWhlocPr EWhloc6w EWhloc3m EWhloc6m 
IWHPr IWH6w IWH3m IWH6m_ 
ChDescribe 
L( L __ 
-
TrPr Tr6w Tr3m Tr6m_ 
NEBPr NEB6w NEB3m NEB6m_ 
TOLPr TOL6w TOL3m TOL6m3 
Rch6w Rch3m Rch6m_ L! L 
PATHPr PATH6w PATH3m PATH6m_ 
SBIPr 
NECC6w NECC3m NECC6m_ 
Radd 
abd 
AnorPr Anor6w Anor3m Anor6m_ 
HepPr Hep6w Hep3m Hep6m_ 
SplPr Spl6w Spl3m _ Spl6m_ 
PLnPr PLn6w PLn3m PLn6m_ 
AscPr Asc6w Asc3m Asc6m_ 
PLEPr PLE6w PLE3m PLE6m_ 
GOR GORRx GORSx 
Ach6w Ach3m Ach6m_ 
Abdadd 
CVS 
CVnorPr CVnor6w CVnor3m CVnor6m_ 
CVch6w CVch3m CVch6m_ 
CVadd 
ens 
CNnorPr CNnor6w CNnor3m CNnor6m_ 
TBMPr TBM6w TBM3m TBM6m_ 
HcefPr Hcef6w Hcef3m Hcef6m_ 
TbclPr Tbcl6w Tbcl3m Tbcl6m_ 
HlossPr Hloss6w Hloss3m Hloss6m_ 
VlossPr Vloss6w Vloss3m Vloss6m_ 
LTSxPr LTSx6w LTSx3m LTSx6m_ 
CNabnPr CNabn6w CNabn3m CNabn6m_ 
SeizPr Seiz6w Seiz3m Seiz6m 
DevrPr Devr6w Devr3m Devr6mlt L 
CNch6w CNch3m CNch6m_ 
CNadd 
other systems 
. IPPE.\'DffE'l 
ENTnorPr 
ENTch6w 
ENTnor6w 
ENTch3m 
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ENTnor3m ENTnor6m _ 
ENTch6m_ 
ENTadd.~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-
SknorPr Sknor6w Sknor3m Sknor6m_ 
Skch6w Skch3m Skch6m_ 
Skadd.~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~-~--
SpnorPr _ Spnor6w _ Spnor3m _ Spnor6m_ 
RMSSnorPr RMSSnor6w RMSSnor3m RMSSnor6m _ 
MSSch6w MSSch3m MSSch6m_ 
MSSadd.~~~-~~~~-~-----------------------
Otherl~~~-~-~-~~~~~~~~~~-~-~~~~-~-~-~~-­
Other2~-~~~~~~--~~~~~~~-~---~-~~~~~~~~~-
0ther3~~~~~~~~~-~~~~~-~~-~-~~~~~~~~~~-~­
Other4~~~~----~~~~~~~-~~~~-~~~~~~~~~~~~-
0ther5~~~~-~-~~~-~~~~~~-~---~~~~~-~-~~~-
Ievent6w Ievent3m Ievent6m 
Ieventadd._~~-~-~~~-~~~~~~~~~~~~~~~~~~~~~-~-
skin tests 
TinePr 
MantPr 
CreacPr 
treatment 
INH Rif 
Tine6w 
Mant6w 
Creac6w 
PZA Etham 
Tine3m 
Mant3m 
Creac3m 
Ethion 
Tine6m_ 
Mant6m_ 
Creac6m_ 
Strep 
Other_~~~--~~-~~~~~-~--~----~~---~~~--~ 
Dose 
Sterdur 
MVTA&D 
Antib 
Compl _ 
Stercourses 
MVTother 
Respsup _ 
Complspec.~~~~~~--~~---~~---
Sterindic. ___ ~~-~--~~--~~~~-
Fe Fedose Folate 
chemistry/micro: tb diagnosis only 
Satypel _ 
Datel 
Protl 
sprotl __ 
ADAl 
Globl 
Cll 
sCll 
Glucl 
GlucLl 
sglucl __ 
Lymphl __ 
Polyl __ 
MNCl 
LDHl 
sLDHl 
histology 
Satype4 
Date4 
Satype2 _ 
Date2 
Prot2 
sprot2 __ 
ADA2 
Glob2 
Cl2 
sC12 
Gluc2 
GlucL2 
sgluc2 __ 
Lymph2 __ 
Poly2 __ 
MNC2 
LDH2 
sLDH2 
Satypes 
Dates 
Satype3 _ 
Date3 
Prot3 
sprot3 __ 
ADA3 
Glob3 
Cl3 
sC13 
Gluc3 
GlucL3 
sgluc3 __ 
Lymph3 __ 
Poly3 __ 
MNC3 
LDH3 
sLDH3 
Satype4_ 
Date4 ___ _ 
Prot4 __ 
sprot __ 
ADA4 __ 
Glob4 __ 
Cl4 
sC14 __ 
Gluc4 __ 
GlucL4_ 
sgluc4 __ 
Lymph4 __ 
Poly4 __ 
MNC4 __ 
LDH4 __ 
sLDH4 __ 
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SugTB4 _ SugTB5 _ 
Inconcl4 Inconcl5 
AFB+4 AFB+5 
mycobacterial culture 
Satype6 Satype7 Satype8 Satype9 SatypelO _ 
Date6 Date7 Date8 Date9 DatelO <dd/ 
mCult6 Cult7 Cult8 Cult9 CultlO 
Mtb Mtb7 Mtb8 Mtb9 MtblO 
Sens6 Sens7 Sens8 Sens9 SenslO 
Other6 Other? Other8 Other9 OtherlO 
cultadd 
